Neoplasms Clinical Trials

Anniston : Regional Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Bessemer : Birmingham Hematology and Oncology Associates, LLC Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Birmingham : Birmingham Hematology and Oncology Associates, LLC Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Birmingham : Urology Centers of Alabama, PC

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Birmingham : Pfizer Investigational Site

A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer

View More »

Birmingham : Investigational Site Number 840003 Updated

Early Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Birmingham : Investigational Site Number 840010 Updated

Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen

Birmingham : University Of Alabama at Birmingham

Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy

Birmingham : University of Alabama at Birmingham

Safety Study of Adenovirus/PNP Coupled With Fludarabine Phosphate to Treat Solid Tumors

Birmingham :

Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer

Birmingham :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Birmingham : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms

Birmingham : University of Alabama at Birmingham

Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated

Homewood :

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Mobile : Providence Cancer Center at Providence Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Anchorage : Alaska Clinical Research Center, Llc

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Anchorage : Alaska Clinical Research Center, LLC

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Anchorage : Providence Cancer Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Anchorage : Alaska Regional Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Anchorage :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

View More »

Fairbanks : Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Fairbanks : Fairbanks Memorial Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Little Rock : 1200.131.00171 Boehringer Ingelheim Investigational Site Updated

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Chandler : Ironwood Cancer and Research Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Chandler : New Horizons Women's Care, LLC

An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+

Glendale : Palo Verde Cancer Specialists Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Goodyear : Weatern Regional Medical Center / Cancer Treatment Centers of America Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Phoenix :

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

View More »

Phoenix : Arizona OB/GYN Affiliates, PC

An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+

Phoenix : Precision Trials

An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+

Phoenix : Barrow Neurological Institute, St. Joseph's Hospital and Medical Center

In Vivo Confocal Microscopy Tumor Atlas Study

Phoenix :

Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

Phoenix : Investigational Site Number 840007 Updated

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

Phoenix : Maricopa Integrated Health System

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

Phoenix :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Scottsdale : Investigational Site Number 840002

A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors

Scottsdale : Pinnacle Oncology Hematology,

A Dose Escalation Study of OMP-54F28 in Subjects With Solid Tumors

Scottsdale : Scottsdale Clinical Research Institute

A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion in Patients With Solid Tumors

Scottsdale : Scottsdale Healthcare

A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors

Scottsdale : AVEO Clinical Site

A Phase 1 Dose Escalation Study of AV-203, an ERBB3 Inhibitory Antibody, in Subjects With Advanced Solid Tumors

Scottsdale : TGen Clinical Research Service at Scottsdale Healthcare

A Phase 1 Dose Escalation Trial of ASG-5ME in Pancreatic or Gastric Adenocarcinoma

Scottsdale : Virginia G. Piper Cancer Center at Scottsdale Healthcare

A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors

Scottsdale : 21st Century Oncology Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Scottsdale : Pinnacle Oncology Hematology, Oncology Research Associates, PLLC Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Scottsdale : Mayo Clinic

A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)

Scottsdale : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study in Advanced Cancer

Scottsdale : GSK Investigational Site

A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib

Scottsdale :

A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer

Scottsdale : Mayo Clinic Arizona - Cancer Clinical Research Unit

A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers

Scottsdale : Updated

BAY80-6946 Open Label, Phase I Study in Patients With Advanced Cancer

Scottsdale : GSK Investigational Site

Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents

Scottsdale : Investigational Site Number 840003

Dose Escalation Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies

Scottsdale :

Dose Escalation Study of MLN0128 in Subjects With Advanced Malignancies

Scottsdale : Mayo Clinic Arizona

Dose-escalation Study of Oral CX-4945

Scottsdale : Virginia G. Piper Cancer Center at Scottsdale Healthcare

Evaluation of Safety, Tolerability, PK & PD of Intravenous VX15/2503 in Patients With Advanced Solid Tumors

Scottsdale : Mayo Clinic in Arizona Updated

Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction

Scottsdale : Scottsdale Healthcare

Phase 1 Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Solid Tumors

Scottsdale : Oncology Research Associates

Phase 1 Study of ONX 0912 Administered Orally in Patients With Advanced Refractory or Recurrent Solid Tumors

Scottsdale : Mayo Clinic Arizona

Phase 1/2, Open-label, Dose-escalation Study of ISIS-STAT3Rx, Administered to Patients With Advanced Cancers

Scottsdale :

Phase Ib Study of PI3(Phosphoinositol 3)-Kinase Inhibitor BAY80-6946 With MEK (Mitogen-activated Protein Kinase) Inhibitor BAY86-9766 in Patients With Advanced Cancer

Scottsdale : Oncology Research Associates, Pllc D/B/A

Safety Study of IL-21/Anti-PD-1 Combination in the Treatment of Solid Tumors

Scottsdale : Site Reference ID/Investigator# 64046

Study of ABT-700 in Subjects With Advanced Solid Tumors

Scottsdale : TGen Clinical Research Services at Scottsdale Healthcare

Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma

Scottsdale : TGen Clinical Research Services

Study of BMN 673, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors

Scottsdale :

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

Scottsdale :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Scottsdale : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms

Scottsdale :

Study of the Safety and Pharmacokinetics of MPDL3280A Administered Intravenously As a Single Agent to Patients With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies

Scottsdale : Pinnacle Oncology Hematology

Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated

Scottsdale : Investigational Site Number 840008

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Scottsdale : Pinnacle Oncology Hematology

Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors

Sedona :

A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment Into Clinical Research Studies of Zelboraf (Vemurafenib)

Tucson : Arizona Cancer Center

A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion in Patients With Solid Tumors

Tucson : Urological Associates of Southern Arizona, P.C. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Tucson : Arizona Oncology Associates, PC - HOPE Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Tucson : Arizona Institute of Urology Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Tucson :

A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment Into Clinical Research Studies of Zelboraf (Vemurafenib)

Tucson : GSK Investigational Site

A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib

Tucson : Urology Associates of Southern Arizona

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Tucson :

A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers

Tucson :

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Tucson : Visions Clinical Research - Tucson

An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+

Tucson : The University of Arizona Cancer Center - North Campus

Clinical Study of WT2725 in Patients With Advanced Solid Malignancies

Tucson : GSK Investigational Site

Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents

Tucson : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Tucson :

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Tucson : Arizona Cancer Center at University Medical Center North Updated

S0820, Adenoma and Second Primary Prevention Trial

Tucson : University of Arizona Health Sciences Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Tucson : Arizona Cancer Center at UMC Orange Grove Updated

S0820, Adenoma and Second Primary Prevention Trial

Tucson : Research Site

Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer

Tucson :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Tucson : Southern Arizona VA Medical Center

The Study of Barrett's Esophagus: What Are the Factors of Progression

Fayetteville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Fayetteville : Pfizer Investigational Site

An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)

Fayetteville : Highlands Oncology Group Dept of Highlands Oncology Grp

Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors

Jonesboro : NEA Medical Clinic - East Matthews

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Little Rock : Little Rock Hematology Oncology: A Division of CARTI Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

View More »

Little Rock : Call for Information (Investigational Site 0385)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Little Rock : 1200.43.00101 Boehringer Ingelheim Investigational Site Updated

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Little Rock : Arkansas Cancer Research Center at University of Arkansas for Medical Sciences

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Little Rock : University of Arkansas for Medical Sciences Updated

S0820, Adenoma and Second Primary Prevention Trial

Rogers : Pfizer Investigational Site

An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)

Rogers : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Alhambra : Call for Information (Investigational Site 0238)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Anaheim : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Antioch : Kaiser Permanente-Deer Valley Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Bakersfield : Call for Information (Investigational Site 0326)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Bakersfield : Comprehensive Blood and Cancer Center

Melphalan and Panobinostat in Treating Patients With Recurrent Multiple Myeloma

View More »

Berkeley : Alta Bates Summit Medical Center

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Berkeley : Call for Information (Investigational Site 0015)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Berkeley : Alta Bates Summit Medical Center-Herrick Campus Updated

S0820, Adenoma and Second Primary Prevention Trial

Burbank :

A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment Into Clinical Research Studies of Zelboraf (Vemurafenib)

Burbank : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Burbank : Call for Information (Investigational Site 0324)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Burlingame : Mills - Peninsula Hospitals Updated

S0820, Adenoma and Second Primary Prevention Trial

Campbell : Call for Information (Investigational Site 0312)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Campbell : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Castro Valley : East Bay Radiation Oncology Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Castro Valley : Valley Medical Oncology Consultants - Castro Valley

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Chula Vista : South County Hematology/Oncology Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Colton :

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Concord : Updated

A Pharmacokinetics Study to Investigate the Effect of Rifampin on Vemurafenib in Patients With BRAFV600 Mutation-Positive Metastatic Malignancy

Concord : Cancer Care Center at John Muir Health - Concord Campus

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Corona : Wilshire Oncology Medical Group, Inc. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Corona : Call for Information (Investigational Site 0425)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Duarte : City of Hope National Medical Center

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

Duarte : Research Site

Open Label Extension Study of Conatumumab and AMG 479

Duarte : City of Hope National Medical Center

Phase I Study of LB-100 With Docetaxel in Solid Tumors

Duarte : City of Hope Comprehensive Cancer Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Duarte : City of Hope Medical Center

Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Metastatic Breast Cancer

Encino : Urology Specialists of Southern California Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Fair Oaks : Call for Information (Investigational Site 0380)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Fairfield : North Bay Cancer Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Fountain Valley : Robert A. Moss, M.D., F.A.C.P., Inc Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Fremont : Valley Medical Oncology

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Fremont : Kaiser Permanente, Fremont Updated

S0820, Adenoma and Second Primary Prevention Trial

Fresno : Updated

A Study of The Impact of Severe Hepatic Impairment on the Pharmacokinetics and Safety of Vemurafenib in BRAF V600 Mutation-Positive Cancer Patients

Fresno : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Fresno : Kaiser Permanente Updated

S0820, Adenoma and Second Primary Prevention Trial

Fullerton : Pfizer Investigational Site Updated

A Study of PD-0332991 + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer

Gilroy :

Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

Glendale : Pacific Shores Medical Group Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Glendora : Wilshire Oncology Medical Group, Inc. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Grass Valley : Sierra Nevada Cancer Center at Sierra Nevada Memorial Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Greenbrae :

A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer

Greenbrae : Sutter Health Western Division Cancer Research Group Updated

S0820, Adenoma and Second Primary Prevention Trial

Hayward : Kaiser Permanente, Hayward Updated

S0820, Adenoma and Second Primary Prevention Trial

Highland : Beaver Medical Group

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Highland : Call for Information (Investigational Site 0430)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Highland :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Huntington Beach : Pacific Shores Medical Group Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

La Jolla : UCSD Medical Center - La Jolla Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

La Jolla : UCSD Moores Cancer Center Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

La Jolla : Moores UCSD Cancer Center Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

La Jolla : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2875358 in Patients With Advanced Cancer

La Jolla : Pfizer Investigational Site

A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer

La Jolla : Call for Information (Investigational Site 0251)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

La Jolla : UC San Diego Moores Cancer Center

Clinical Study of WT2725 in Patients With Advanced Solid Malignancies

La Jolla : Moores UC San Diego Cancer Center

Phase 1/2, Open-label, Dose-escalation Study of ISIS-STAT3Rx, Administered to Patients With Advanced Cancers

La Jolla : Moores University of California San Diego Cancer Center

Safety and PK Study of RRx-001 in Cancer Subjects

La Jolla : University of California, San Diego

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

La Jolla :

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

La Jolla :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

La Jolla : Investigational Site Number 840004

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

La Mesa : Cancer Center Oncology Medical Group Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

La Mesa :

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

La Mesa : Grossmont Center for Clinical Research

An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+

La Verne : Wilshire Oncology Medical Group, Inc. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Loma Linda : Loma Linda University Medical Center

A Study of DS-2248, in Subjects With Advanced Solid Tumors

Loma Linda : Investigational Site Number 840013

Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment

Long Beach : Pacific Shores Medical Group Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Long Beach : Breastlink Medical Group, Incorporated at Long Beach Memorial Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Los Alamitos : Pacific Shores Medical Group Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Los Angeles : UCLA/ University of California Los Angeles Div. of Hematology/Oncology

A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies

Los Angeles : Investigational Site Number 840004

A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors

Los Angeles : Research Site

A Phase 1 Dose Escalation Study of AMG 780 in Adult Subjects With Advanced Solid Tumor

Los Angeles : University of California Los Angeles

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

Los Angeles : USC Norris Comprehensive Cancer Center

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

Los Angeles : Cedars-Sinai Medical Center

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

Los Angeles : Cedars-Sinai Medical Center

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Los Angeles : Tower Urology Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Los Angeles : USC / Norris Comprehensive Cancer Center Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Los Angeles : UCLA Institute of Urologic Oncology, UCLA Medical Center Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Los Angeles :

A Safety Study of Abiraterone Acetate Administered in Combination With Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Los Angeles : Research Site

A Study of AMG 337 in Subjects With Advanced Solid Tumors

Los Angeles :

A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer

Los Angeles : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2875358 in Patients With Advanced Cancer

Los Angeles : Pfizer Investigational Site Updated

A Study of PD-0332991 + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer

Los Angeles :

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Los Angeles : Research Site

A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumor

Los Angeles : UCLA/ University of California Los Angeles Div. of Hematology/Oncology

A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor Patients

Los Angeles : 1200.89.10001 Boehringer Ingelheim Investigational Site Updated

Afatinib (BIBW2992) in HER2-overexpressing Inflammatory Breast Cancer

Los Angeles : Updated

An Extension (Rollover) Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Malignancies Previously Enrolled in an Antecedent Vemurafenib Protocol

Los Angeles : Pfizer Investigational Site

Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients

Los Angeles :

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Los Angeles :

Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

Los Angeles : 1200.131.00178 Boehringer Ingelheim Investigational Site Updated

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Los Angeles : Investigational Site Number 840008 Updated

Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen

Los Angeles : Investigational Site Number 840009 Updated

Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen

Los Angeles : Cedars Sinai Medical Center SC

Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors

Los Angeles : USC/Norris Comprehensive Cancer Center and Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Los Angeles : University of Southern California Updated

S0820, Adenoma and Second Primary Prevention Trial

Los Angeles : Los Angeles County-USC Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Los Angeles : University of Southern California, Norris Comprehensive Cancer Center

Safety and Efficacy Study of PRI-724 in Subjects With Advanced Solid Tumors

Los Angeles :

Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer

Los Angeles :

Sorafenib Long Term Extension Program (STEP)

Los Angeles :

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

Los Angeles : Pfizer Investigational Site

Study Of PI3K/mTOR Inhibitors In Combination With A MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer

Los Angeles :

Study of the Safety and Pharmacokinetics of MPDL3280A Administered Intravenously As a Single Agent to Patients With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies

Los Angeles : Samuel Oschin Comprehensive Cancer Institute

Study to Investigate the Pharmacolkinetics of Aldoxorubicin (INNO-206;DOXO-EMCH) Administered as a 30 Minute Infusion Every 3 Weeks in Subjects With Advanced Solid Tumors

Los Angeles : Investigational Site Number 840005

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Los Angeles : Cedars Sinai Medical Center

Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors

Marina del Rey : Prostate Oncology Speciality Inc. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Marina del Rey :

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

Martinez : Contra Costa Regional Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Marysville : Tibotec Therapeutics - Division of Ortho Biotech Products, LP

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Merced : Mercy Cancer Center at Mercy Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Mission Hills : Call for Information (Investigational Site 0252)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Mission Hills : Call for Information (Investigational Site 0121)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Modesto : Kaiser Permanente-Modesto Updated

S0820, Adenoma and Second Primary Prevention Trial

Montebello :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Mountain View : El Camino Hospital Cancer Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Murrieta : Tri Valley Urology Medical Group Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Newport Beach : Gynecologic Oncology Associates

Paclitaxel, Carboplatin and Vorinostat for the Treatment of Advanced Stage Ovarian Carcinoma

Oakland : Alta Bates Summit Medical Center - Summit Campus

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Oakland : Highland General Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Oakland : Epic Care - Oakland

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Oakland : Larry G Strieff MD Medical Corporation

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Oakland : Bay Area Breast Surgeons, Incorporated

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Oakland : CCOP - Bay Area Tumor Institute

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Oakland : Tom K Lee, Incorporated

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Oakland : Kaiser Permanente-Oakland Updated

S0820, Adenoma and Second Primary Prevention Trial

Oceanside : North County Oncology Medical Group, Inc. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Orange : Medical Oncology Care Associates (MOCA) Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Orange : Hematology-Oncology Medical Group of Orange County, Inc. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Orange : The Center for Cancer Prevention and Treatment, St. Joseph Hospital Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Orange : Department of Obstetrics and Gynecology, University of California, Irvine

A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)

Orange : UC Irvine Medical Center, Chao Family Comprehensive Cancer Center

A Study of DS-2248, in Subjects With Advanced Solid Tumors

Orange : Pfizer Investigational Site

A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer

Orange : Call for Information (Investigational Site 0433)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Orange : 1200.131.00181 Boehringer Ingelheim Investigational Site Updated

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Orange : St. Joseph Hospital Regional Cancer Center - Orange

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Orange : Saint Joseph Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Orange : University of California Medical Center At Irvine-Orange Campus Updated

S0820, Adenoma and Second Primary Prevention Trial

Orange : Children's Hospital of Orange County

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Orange : University of California - Irvine

Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma)

Orange :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Orange : University of California Irvine Medical Center

TheraSphere for Treatment of Unresectable Hepatocellular Carcinoma

Orange : University of California Irvine

Tracking Renal Tumors After Cryoablation Evaluation

Oxnard : PMK Medical Group, Inc., DBA Ventura County Hematology Oncology Specialists Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Palm Springs : Comprehensive Cancer Center

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

Palo Alto :

Study of KB004 in Subjects With Hematologic Malignancies

Palo Alto : Investigational Site Number 840011

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Pasadena : Wilshire Oncology Medical Group, Inc. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Pasadena : Huntington Memorial Hospital/Hill Breast Center

Earlier Breast Cancer Detection Using Automated Whole Breast Ultrasound With Mammography, Including Cost Comparisons

Pasadena : South Pasadena Cancer Center

Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Metastatic Breast Cancer

Pleasant Hill : Call for Information (Investigational Site 0381)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Pleasant Hill : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Pleasant Hill : Research Site

EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer

Pleasanton : Valley Medical Oncology Consultants Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Pleasanton : Valley Medical Oncology Consultants

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

Pleasanton : Valley Medical Oncology Consultants - Pleasanton

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Pomona : Wilshire Oncology Medical Group, Inc. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Rancho Cucamonga : Wilshire Oncology Medical Group, Inc. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Rancho Cucamonga :

A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment Into Clinical Research Studies of Zelboraf (Vemurafenib)

Rancho Mirage : Call for Information (Investigational Site 0350)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Rancho Mirage :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Redondo Beach : Pfizer Investigational Site Updated

A Study of PD-0332991 + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer

Redwood City : Kaiser Permanente-Redwood City Updated

S0820, Adenoma and Second Primary Prevention Trial

Richmond : Kaiser Permanente-Richmond Updated

S0820, Adenoma and Second Primary Prevention Trial

Riverside : Call for Information (Investigational Site 0418)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Roseville : Sutter Roseville Medical Center Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Roseville : Call for Information (Investigational Site 0236)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Roseville : Kaiser Permanente-Roseville Updated

S0820, Adenoma and Second Primary Prevention Trial

Sacramento : Radiological Associates of Sacramento

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

Sacramento : Sutter Cancer Center / Sacramento Center for Hematology and Medical Oncology Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Sacramento : Sutter Memorial Hospital Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Sacramento : University of California Davis Cancer Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Sacramento : Kaiser Permanente - Sacramento Updated

S0820, Adenoma and Second Primary Prevention Trial

Sacramento : Kaiser Permanente-South Sacramento Updated

S0820, Adenoma and Second Primary Prevention Trial

Sacramento : University of California - Davis

Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma)

Sacramento : University of California Davis Cancer Center

Study of Cisplatin and Pemetrexed in Combination With Panobinostat in Solid Tumors

Sacramento : University of California at Davis

Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer

Salinas : Investigational Site Number 840011 Updated

Early Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

San Bernardino : San Bernardino Urological Associates

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

San Diego : University of California, San Diego: Moores Cancer Center, Site #099

A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113

San Diego : San Diego Clinical Trials

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

San Diego : Sharp Memorial Hospital

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

San Diego : Sharp Rees-Stealy Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

San Diego : Sharp Clinical Oncology Research Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

San Diego : Medical Oncology Associates Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

San Diego : Genesis Research Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

San Diego : UCSD Medical Center - Hillcrest Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

San Diego : Genesis Research

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

San Diego : Pfizer Investigational Site

A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer

San Diego : Sharp Memorial Hospital

A Study to Assess PV-10 Chemoablation of Cancer of the Liver

San Diego : University of California at San Diego, Moores Cancer Ctr UCSD

Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors

San Diego :

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

San Diego : UCSD Moores Cancer Research Institute

Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)

San Diego : San Diego Pacific Oncology & Hematology Assoc Inc.

Phase 1 Pharmacokinetics Study of Oral MLN9708 in Patients With Advanced Nonhematologic Malignancies or Lymphoma

San Diego : University of California, San Diego

Safety and Efficacy of Cryoablation Combined With Radiation Therapy for the Palliation of Painful Bone Metastases

San Diego :

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

San Francisco : UCSF-Helen Diller Family Comprehensive Cancer Care Center

A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors

San Francisco : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of IMC-CS4 in Subjects With Advanced Solid Tumors

San Francisco : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2875358 in Patients With Advanced Cancer

San Francisco : Pfizer Investigational Site Updated

A Study of PD-0332991 + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer

San Francisco : Investigational Site Number 840005

Dose Escalation Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies

San Francisco : UCSF Helen Diller Family Comprehensive Cancer Center Updated

Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer

San Francisco : UCSF Helen Diller Family Comprehensive Cancer Center

Eribulin in Combination With Cyclophosphamide in Patients With Solid Tumor Malignancies

San Francisco : Research Site

Panitumumab Pediatric Study

San Francisco : UCSF Helen Diller Family Comprehensive Cancer Center

Phase I Tolerability, Efficacy, and Safety Study of Pazopanib in Combination With PCI-24781 in Patients With Metastatic Solid Tumors

San Francisco : UCSF Helen Diller Family Comprehensive Cancer Center

Phase I/Ib Dose-escalation of Dinaciclib With Weekly Paclitaxel for Advanced Solid Tumor Malignancies & Assessment of MYC Oncogene Overexpression

San Francisco : Investigational Site Number 840003 Updated

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

San Francisco : Investigational Site Number 840004 Updated

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

San Francisco : UCSF Helen Diller Family Comprehensive Cancer Center

Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib

San Francisco : Kaiser Permanente-San Francisco Updated

S0820, Adenoma and Second Primary Prevention Trial

San Francisco : California Pacific Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

San Francisco : Investigational Site Number 840014

Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment

San Francisco : UCSF

Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors

San Jose : Kaiser Permanente-Santa Teresa-San Jose Updated

S0820, Adenoma and Second Primary Prevention Trial

San Luis Obispo : Pfizer Investigational Site Updated

A Study of PD-0332991 + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer

San Marcos :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

San Pablo : Doctors Medical Center - San Pablo Campus

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

San Rafael : Kaiser Permanente-San Rafael Updated

S0820, Adenoma and Second Primary Prevention Trial

Santa Ana : Edward Alexson, MD, Inc. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Santa Barbara : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Santa Clara : Kaiser Permanente Medical Center - Santa Clara Updated

S0820, Adenoma and Second Primary Prevention Trial

Santa Maria : Pfizer Investigational Site Updated

A Study of PD-0332991 + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer

Santa Maria : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Santa Monica : Call for Information (Investigational Site 0009)

A Dose Escalation Study of MK1775 in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001 AM7)

Santa Monica : UCLA Santa Monica Hematology-Oncology

A Dose Escalation Study of OMP-18R5 in Subjects With Solid Tumors

Santa Monica : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Phase 1 Study of LY2835219 In Participants With Advanced Cancer

Santa Monica : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2875358 in Patients With Advanced Cancer

Santa Monica : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY3007113 in Participants With Advanced Cancer

Santa Monica : UCLA Hematology-Oncology Santa Monica

Phase 1 Pharmacokinetics Study of Oral MLN9708 in Patients With Advanced Nonhematologic Malignancies or Lymphoma

Santa Monica : Sarcoma Oncology Center

Phase 1b Study to Investigate the Safety and Maximum Tolerated Dose of Aldoxorubicin (INNO-206) Plus Doxorubicin HCL in Subjects With Advanced Solid Tumors

Santa Monica : University of California Los Angeles (UCLA)

Study of BMN 673, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors

Santa Monica : Pfizer Investigational Site

Study Of PI3K/mTOR Inhibitors In Combination With A MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer

Santa Monica : Premiere Oncology

Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated

Santa Monica : UCLA Hematology-Oncology

Study of VGX-100 Administered Alone and Co-administered With Bevacizumab in Adult Subjects With Advanced Solid Tumors

Santa Rosa : Sutter Pacific Medical Foundation Updated

S0820, Adenoma and Second Primary Prevention Trial

Santa Rosa : Kaiser Permanente-Santa Rosa Updated

S0820, Adenoma and Second Primary Prevention Trial

South Pasadena : City of Hope South Pasadena

A Study of DS-2248, in Subjects With Advanced Solid Tumors

South San Francisco : Kaiser Permanente-South San Francisco Updated

S0820, Adenoma and Second Primary Prevention Trial

Spring Valley : Call for Information (Investigational Site 0237)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Stanford : Stanford Advanced Medical Center

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Stanford : Stanford Cancer Center - Stanford University

A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers

Stanford : Call for Information (Investigational Site 0341)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Stanford : Stanford University School of Medicine

Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma

Stanford : Stanford University School of Medicine

Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer

Stanford : Stanford University Medical Center

Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of Urelumab (BMS-663513) in Subjects With Advanced and/or Metastatic Solid Tumors and Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

Stanford :

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

Stanford :

Study of the Safety and Pharmacokinetics of MPDL3280A Administered Intravenously As a Single Agent to Patients With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies

Stockton : Call for Information (Investigational Site 0242)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Stockton : Kaiser Permanente-Stockton Updated

S0820, Adenoma and Second Primary Prevention Trial

Torrance :

A Study of RO5185426 (Vemurafenib) in Patients With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation

Truckee : Tahoe Forest Cancer Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Vacaville : Kaiser Permanente Medical Center-Vacaville Updated

S0820, Adenoma and Second Primary Prevention Trial

Vallejo : Kaiser Permanente-Vallejo Updated

S0820, Adenoma and Second Primary Prevention Trial

Vallejo : Sutter Solano Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Vallejo :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Walnut Creek : Contra Costa Oncology Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Walnut Creek : John Muir/Mt. Diablo Comprehensive Cancer Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Walnut Creek : Kaiser Permanente-Walnut Creek Updated

S0820, Adenoma and Second Primary Prevention Trial

West Covina : Wilshire Oncology Medical Group, Inc. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

West Hollywood : James R. Berenson MD, Incorporated

Melphalan and Panobinostat in Treating Patients With Recurrent Multiple Myeloma

Aurora : University of Colorado Dept. of Anschutz Cancer (3)

A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies

Aurora : University of Colorado Denver -RCI-South Tower

A Dose Escalation Study of OMP-52M51 in Subjects With Solid Tumors

Aurora : University of Colorado Hospital

A Dose Escalation Study of OMP-54F28 in Subjects With Solid Tumors

Aurora : Updated

A Multiple-Ascending-Dose Study of the Safety and Tolerability of REGN421(SAR153192) in Patients With Advanced Solid Malignancies

Aurora : University of Colorado Hospital, Site #015

A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113

View More »

Aurora : University of Colorado

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Aurora : Rocky Mountain Cancer Centers Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Aurora : Pfizer Investigational Site

A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer

Aurora : Call for Information (Investigational Site 0444)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Aurora : Investigational Site Number 840007 Updated

Cabazitaxel in Pediatric Patients With Refractory Solid Tumors Including Central Nervous System Tumors

Aurora : Children's Hospital Colorado Updated

Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors

Aurora : University of Colorado Denver

Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors

Aurora :

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Aurora : Aurora Presbyterian Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Aurora : University of Colorado Denver

Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment

Aurora : Research Site

Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours

Aurora :

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

Aurora :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Aurora : Pfizer Investigational Site

Study Of PI3K/mTOR Inhibitors In Combination With A MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer

Boulder : Rocky Mountain Cancer Centers Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Boulder : Boulder Community Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Colorado Springs : Rocky Mountain Cancer Centers Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Colorado Springs : Penrose Cancer Center at Penrose Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Colorado Springs : Memorial Hospital Cancer Center - Colorado Springs

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Denver : Rose Breast Center

A Multicenter "Ablate and Resect" Study of Novilase® Interstitial Laser Therapy for the Ablation of Small Breast Cancers

Denver : The Urology Center of Colorado

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Denver : Rocky Mountain Cancer Centers Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Denver : The Urology Center of Colorado Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Denver :

A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment Into Clinical Research Studies of Zelboraf (Vemurafenib)

Denver : The Urology Center of Colorado

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Denver :

A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers

Denver :

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Denver : Rocky Mountain Cancer Centers - Denver Midtown

Melphalan and Panobinostat in Treating Patients With Recurrent Multiple Myeloma

Denver : Research Site

Open Label Extension Study of Conatumumab and AMG 479

Denver : Rocky Mountain Cancer Centers

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer

Denver : CCOP - Colorado Cancer Research Program

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Denver : Rose Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Denver : Presbyterian - St. Luke's Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Denver : St. Anthony Central Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Denver : Porter Adventist Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Denver : St. Joseph Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Denver : Kaiser Permanente

Tracking Renal Tumors After Cryoablation Evaluation

Englewood : Call for Information (Investigational Site 0304)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Englewood : Swedish Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Fort Collins : Front Range Cancer Specialists

Dose-escalation Study of Oral CX-4945

Fort Collins : Poudre Valley Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Fort Collins : Front Range Cancer Specialists

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Golden : Western Oncology/Hematology Associates, PC Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Grand Junction : Pfizer Investigational Site Updated

A Study of PD-0332991 + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer

Grand Junction : St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Greeley : North Colorado Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Lakewood : Rocky Mountain Cancer Centers Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Lakewood :

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Littleton : Rocky Mountain Cancer Centers Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Littleton : Littleton Adventist Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Littleton :

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

Lone Tree : Rocky Mountain Cancer Centers Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Lone Tree : Sky Ridge Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Longmont : Rocky Mountain Cancer Centers Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Longmont : Hope Cancer Care Center at Longmont United Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Loveland : Front Range Cancer Specialists

Dose-escalation Study of Oral CX-4945

Loveland : McKee Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Parker : Rocky Mountain Cancer Centers Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Parker : Advanced Urology, PC Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Parker : Parker Adventist Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Pueblo : Rocky Mountain Cancer Centers Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Pueblo : St. Mary - Corwin Regional Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Thornton : Rocky Mountain Cancer Centers Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Thornton : North Suburban Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Wheat Ridge : Exempla Lutheran Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Farmington : University of Connecticut Health Center

A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer

Farmington : University of Connecticut Health Center - John Dempsey Hospital/Neag Comprehensive Cancer Center Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Hartford : Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Hartford : Saint Francis Hospital and Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Middlebury : Connecticut Clinical Research Center, LLC

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

View More »

New Britain : Grove Hill Clinical Research, Grove Hill Medical Center, Urology Center of Grove Hill Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

New Haven : Yale University Comprehensive Cancer Center

A Clinical Study of PHY906 as a Modulator of CPT-11 in Patients With Metastatic Colorectal Cancer

New Haven :

A Phase 1 Study of IPI-145 in Patients With Advanced Hematologic Malignancies

New Haven : Yale University, Site #033

A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113

New Haven : Yale University

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

New Haven : The Urology Center, PC Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

New Haven :

A Study of RO5185426 (Vemurafenib) in Patients With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation

New Haven : Yale Comprehensive Cancer Center at Yale University School of Medicine

A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies

New Haven : 1200.131.00185 Boehringer Ingelheim Investigational Site Updated

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

New Haven :

Sorafenib Long Term Extension Program (STEP)

New Haven : Research Site

Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours

New Haven :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

New Haven :

Study of the Safety and Pharmacokinetics of MPDL3280A Administered Intravenously As a Single Agent to Patients With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies

Norwalk : Research Site

A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors

Norwalk : Norwalk Hospital Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Norwalk : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Norwich : Eastern Connecticut Hematology and Oncology Associates Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Southington :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Stamford : The Stamford Hospital Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Stamford : Stamford Hospital

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

Torrington : Call for Information (Investigational Site 0376)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Lewes : Tunnell Cancer Center at Beebe Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Newark : Call for Information (Investigational Site 0274)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Newark : Christiana Hospital

Breath Test for Early Detection of Lung Cancer

Newark : GSK Investigational Site Updated

Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer

Newark : CCOP - Christiana Care Health Services

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

View More »

Wilmington : Alfred I. duPont Hospital for Children

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Washington : Washington Cancer Institute

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Washington : Howard University Cancer Center & Howeard University Hospital Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Washington : GSK Investigational Site

A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib

Washington :

A Study of MPDL3280A in Combination With Avastin (Bevacizumab) or With Avastin Plus Chemotherapy in Patients With Advanced Solid Tumors

Washington : Call for Information (Investigational Site 0358)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

View More »

Washington : Call for Information (Investigational Site 0424)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Washington : Call for Information (Investigational Site 0309)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Washington : GSK Investigational Site Updated

ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D

Washington : GSK Investigational Site

Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents

Washington : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Washington : Research Site

Panitumumab Pediatric Study

Washington : Washington Cancer Institute

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

Washington : Investigational Site Number 840020

Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment

Washington :

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

Washington : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms

Atlantis : The Breast Institute at JFK Medical

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

Aventura : South Florida Medical Research

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Aventura : Mount Sinai Comprehensive Cancer Center Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Aventura :

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Boynton Beach :

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

View More »

Boynton Beach : Call for Information (Investigational Site 0266)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Boynton Beach : Visions Clinical Research

An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+

Boynton Beach : Pfizer Investigational Site

An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)

Boynton Beach : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Bradenton : Manatee Medical Research Institute, LLC

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Bradenton : Manatee Medical Research Institute, LLC Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Coral Gables : Pfizer Investigational Site

A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer

Coral Gables : Call for Information (Investigational Site 0340)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Coral Gables : Call for Information (Investigational Site 0250)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Coral Gables : GSK Investigational Site

Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study

Crestview : 21st Century Oncology Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Daytona Beach :

Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

Daytona Beach : Halifax Health Center for Oncology

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

Fleming Island : Integrated Community Oncology Network Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Fort Lauderdale :

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Fort Lauderdale : Broward General Medical Center Cancer Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Fort Myers : Florida Urology Physicians

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Fort Myers : 21st Century Oncology Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Fort Myers : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study in Advanced Cancer

Fort Myers : GSK Investigational Site

A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib

Fort Myers :

A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer

Fort Myers : Florida Urology Physicians

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Fort Myers : GSK Investigational Site

Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents

Fort Myers :

Dose Escalation Study of MLN0128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies

Fort Myers : Regional Breast/21st Century Oncology

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

Gainesville : Malcom Randal VAMC

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Hialeah : Call for Information (Investigational Site 0020)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Hollywood : Pfizer Investigational Site Updated

A Study of PD-0332991 + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer

Hudson : Florida Cancer Specialists, PL Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Jacksonville : Cancer Specialists of North Florida Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Jacksonville : Integrated Community Oncology Network Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Jacksonville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2875358 in Patients With Advanced Cancer

Jacksonville : Pfizer Investigational Site Updated

A Study of PD-0332991 + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer

Jacksonville : Call for Information (Investigational Site 0267)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Jacksonville : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Jacksonville : Mayo Clinic

Improving Complete Endoscopic Mucosal Resection (EMR) of Colorectal Neoplasia

Jacksonville :

Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

Jacksonville : University of Florida Jacksonville

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

Jacksonville : Investigational Site Number 840016

Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment

Jacksonville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms

Jacksonville Beach : Integrated Community Oncology Network Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Lake Worth : Altus Research

An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+

Lakeland : Lakeland Regional Cancer Center

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Lakeland : Watson Clinic LLP, Center for Cancer Care & Research, Clark & Daughtrey Medical Group, PA Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Lakeland : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Lakeland : Call for Information (Investigational Site 0384)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Lynn Haven : Northwest Florida Hematology Oncology PA Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Miami : Advanced Medical Specialties Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Miami : Pfizer Investigational Site

A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer

Miami : Call for Information (Investigational Site 0284)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Miami : Call for Information (Investigational Site 0028)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Miami : Call for Information (Investigational Site 0365)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Miami : Call for Information (Investigational Site 0243)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Miami : Call for Information (Investigational Site 0268)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Miami : Call for Information (Investigational Site 0278)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Miami : Pfizer Investigational Site

An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)

Miami : University Of Miami Sylvester Comprehensive Cancer Center

Combination Study of Urelumab and Rituximab in Patients With B-cell Non-Hodgkins Lymphoma or CLL

Miami : GSK Investigational Site

Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects

Miami : University of Miami

Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer

Miami : University of Miami Sylvester Comprehensive Cancer Center

Ixabepilone and Sunitinib Malate in Treating Patients With Progressive Advanced Solid Tumors

Miami : Call for Information (Investigational Site 0248)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Miami : Mount Sinai Medical Center-Miami

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer

Miami Beach : Mount Sinai Comprehensive Cancer Center Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Naples : Premier Oncology Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Naples : Specialists in Urology Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Naples : 21st Century Oncology Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

New Port Richey : Florida Cancer Specialists, PL Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

New Port Richey :

Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

New Port Richey :

Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer

Ocala : Ocala Oncology Center Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Ocala :

A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment Into Clinical Research Studies of Zelboraf (Vemurafenib)

Ocala :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Orange City : Atlantic Urological Associates Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Orange City :

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Orange Park : Integrated Community Oncology Network Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Orlando : M.D. Anderson Cancer Center Orlando

A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer

Orlando : MD Anderson Cancer Center Orlando

A Study of DS-2248, in Subjects With Advanced Solid Tumors

Orlando : Call for Information (Investigational Site 0419)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Orlando : MD Anderson Cancer Center

Breath Test for Early Detection of Lung Cancer

Orlando : Investigational Site Number 840005 Updated

Cabazitaxel in Pediatric Patients With Refractory Solid Tumors Including Central Nervous System Tumors

Orlando : Arnold Palmer Hospital for Children/MD Anderson Cancer Center Orlando Updated

Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors

Orlando :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Palatka : Integrated Community Oncology Network Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Pensacola : Sacred Heart Medical Oncology Groupl Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Pensacola : Sacred Heart Medical Oncology

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Pensacola : Sacred Heart Cancer Center at Sacred Heart Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Plantation : 21st Century Oncology Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Plantation : GSK Investigational Site Updated

Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer

Port St. Lucie : Call for Information (Investigational Site 0259)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Sarasota :

A Phase 1 Study of IPI-145 in Patients With Advanced Hematologic Malignancies

Sarasota : Sarah Cannon Research Institute

A Study of Oral Rucaparib in Patients With gBRCA Mutation Breast or Ovarian Cancer, or Other Solid Tumor

Sarasota :

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Sarasota :

An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid Tumors

Sarasota : Florida Cancer Specialists

Dose Escalation Study of the Safety and Pharmacokinetics of ME-344 Single Agent for Refractory Solid Tumors

Sarasota :

Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

Sarasota : Florida Cancer Specialists / Sarah Cannon Research Institute

Phase 1 Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Solid Tumors

South Miami : Call for Information (Investigational Site 0247)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

St. Augustine : Integrated Community Oncology Network Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

St. Petersburg : Pinellas Urology, Inc.

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

St. Petersburg : All Children's Hospital Updated

Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors

Stuart : Martin Health System

A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer

Stuart : Call for Information (Investigational Site 0339)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Tallahassee : Southeastern Research Group, Inc. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Tampa : H. Lee Moffitt Cancer Center and Research Institute

A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer

Tampa : The Southeastern Center for Digestive Disorders & Pancreatic Cancer

A Study to Assess PV-10 Chemoablation of Cancer of the Liver

Tampa : Moffitt Cancer Center & Research Institute Updated

Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer

Tampa : Call for Information (Investigational Site 0026)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Tampa : Research Site

Open Label Extension Study of Conatumumab and AMG 479

Tampa : Moffitt Cancer Center

Phase 1 Study of MLN0264 in Adult Patients With Advanced Gastrointestinal Malignancies Expressing Guanylyl Cyclase C

Tampa :

Phase 1 Study of PI3 (Phosphatidylinositol-3)-Kinase Inhibitor BAY80-6946 With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer

Tampa : H. Lee Moffitt Cancer Center/University of South Florida Moffitt 4

Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors

Tampa : Moffitt Cancer Center

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer

Tampa : H. Lee Moffitt Cancer Center and Research Institute at University of South Florida

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Tampa : Call for Information (Investigational Site 0007)

Safety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for Participants With Advanced Cancer (MK-8669-049 AM1)

Tampa : Moffitt Cancer Center

Safety Study of IL-21/Anti-PD-1 Combination in the Treatment of Solid Tumors

Tampa :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Tampa :

Study of KB004 in Subjects With Hematologic Malignancies

Tampa : Call for Information (Investigational Site 0004)

Study of Safety and Pharmacokinetics of MK-8242 in Participants With Advanced Solid Tumors (P07650 AM1)

Tampa :

Study of the Safety and Pharmacokinetics of MPDL3280A Administered Intravenously As a Single Agent to Patients With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies

Titusville : Space Coast Medical Associates

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Wellington :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

West Palm Beach : Palm Beach Cancer Institute

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

West Palm Beach : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

West Palm Beach :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Winter Park :

Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

Albany : Phoebe Putney Memorial Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Alpharetta : Georgia Cancer Specialists - Alpharetta Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Athens : Georgia Cancer Specialists - Athens Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Athens : Northeast Georgia Cancer Care

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

Athens :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

View More »

Atlanta : Emory Winship Cancer Institute

A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion in Patients With Solid Tumors

Atlanta : Emory University School of Medicine

A Dose Escalation Study of STA-9090 and Docetaxel in Patients With Solid Tumors

Atlanta : AVEO Clinical Site

A Phase 1 Dose Escalation Study of AV-203, an ERBB3 Inhibitory Antibody, in Subjects With Advanced Solid Tumors

Atlanta : Emory University Hospital, The Emory Clinic, Winship Cancer Institute Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Atlanta : Georgia Cancer Specialists - Emory Midtown Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Atlanta : Georgia Urology, PA Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Atlanta : Piedmont West Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Atlanta : Peachtree Hematology-Oncology Consultants, PC Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Atlanta : Midtown Urology Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Atlanta : Atlanta Hematology Oncology Associates Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Atlanta : GSK Investigational Site

A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib

Atlanta : Emory University

A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer

Atlanta : Emory University Winship Cancer Institute

A Study of Carboplatin, Cetuximab and RAD001 in Advanced Head and Neck Cancer

Atlanta : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2875358 in Patients With Advanced Cancer

Atlanta : Call for Information (Investigational Site 0437)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Atlanta : GSK Investigational Site

Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents

Atlanta : Winship Cancer Institute of Emory University

Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer

Atlanta : Grady Memorial Hospital

Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer

Atlanta : Emory Crawford Long Hospital

Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer

Atlanta : Pfizer Investigational Site

Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients

Atlanta :

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Atlanta : Emory University Winship Cancer Updated

Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction

Atlanta : Emory University

Neoadjuvant Trial of Eribulin Followed by Dose Dense Doxorubicin and Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer

Atlanta :

Phase 1 Dose Escalation Study of ARQ 092 in Adult Subjects With Advanced Solid Tumors and Recurrent Malignant Lymphoma

Atlanta : Emory University

Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors

Atlanta : Investigational Site Number 840005 Updated

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

Atlanta : Emory University Winship Cancer Institute

Re-expression of ER in Triple Negative Breast Cancers

Atlanta : Emory University

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer

Atlanta : Georgia Cancer Specialists

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer

Atlanta : Piedmont Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Atlanta : CCOP - Atlanta Regional

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Atlanta : Saint Joseph's Hospital of Atlanta

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Atlanta : Northside Hospital Cancer Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Atlanta : Emory University

Safety and Efficacy Study of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer

Atlanta : Emory University Winship Cancer Institute Updated

Study of Arsenic Trioxide in Small Cell Lung Cancer

Atlanta :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Atlanta : Emory University Winship Cancer Institute Updated

Study of Everolimus (RAD001)in Combination With Lenalidomide

Atlanta : Emory University Winship Cancer Institute

Trial of XELOX Followed by Radiation Combined With Carboplatin and RAD001 for Esophageal Cancer

Atlanta : Emory University Winship Cancer Institute

Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence Scores

Augusta : Investigational Site Number 840010

A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors

Augusta : Augusta Oncology Associates, PC Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Augusta : Georgia Health Sciences University

An Exploratory Study of Gemcitabine Hydrochloride Oral Formulation (D07001-F4) in Subjects With Malignant Tumors

Augusta : Investigational Site Number 840006 Updated

Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen

Augusta : Georgia Health Sciences University

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

Augusta : Investigational Site Number 840024

Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment

Austell : Northwest Georgia Oncology Centers, P.C. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Austell : WellStar Cobb Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Carrolton : Northwest Georgia Oncology Centers, P.C. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Cartersville : Northwest Georgia Oncology Centers, P.C. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Columbus : John B. Amos Cancer Center Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Columbus : John B. Amos Cancer Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Decatur : Georgia Cancer Specialists - Stemmer Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Decatur : Dekalb Medical Center

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

Decatur : Charles B. Eberhart Cancer Center at DeKalb Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Douglasville : Northwest Georgia Oncology Centers, P.C. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Dublin : Call for Information (Investigational Site 0271)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Duluth : Suburban Hematology-Oncology Associates, PC Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Fayetteville : Georgia Cancer Specialists - Fayetteville Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Fayetteville : Piedmont Fayette Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Gainesville : Northeast Georgia Medical Center

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

Gainesville : Northeast Georgia Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Gainesville : Northeast Georgia Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Lawrenceville : Suburban Hematology-Oncology Associates, PC Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Lawrenceville : Pfizer Investigational Site Updated

A Study of PD-0332991 + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer

Lawrenceville : Gwinnett Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Macon : Georgia Cancer Specialists - Macon Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Marietta : Georgia Cancer Specialists

A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors

Marietta : Northwest Georgia Oncology Centers, P.C. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Marietta : Urology Enterprises Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Marietta : Georgia Cancer Specialists - Kennestone Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Marietta :

Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

Marietta : Kennestone Cancer Center at Wellstar Kennestone Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Marietta :

Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer

Marietta :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Newnan :

Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer

Riverdale : Southern Regional Medical Center

Data Collection of Patients Treated With the ColonRing™ for the Creation of Circular Compression Anastomosis

Riverdale : Southern Regional Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Rome : Harbin Clinic Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Rome : Harbin Clinic Cancer Center - Medical Oncology

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Sandy Springs : Georgia Cancer Specialists - Northside Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Savannah : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Savannah : Curtis and Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Savannah : Saint Joseph's-Candler Health System Updated

S0820, Adenoma and Second Primary Prevention Trial

Snellville : Suburban Hematology-Oncology Associates, PC Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Stockbridge : Georgia Cancer Specialists - Stockbridge Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Stockbridge :

Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

Stockbridge :

Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer

Valdosta : Pearlman Comprehensive Cancer Center at South Georgia Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Aiea : Kapiolani Medical Center at Pali Momi

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Aiea : Kapiolani Medical Center at Pali Momi Updated

S0820, Adenoma and Second Primary Prevention Trial

Honolulu : Call for Information (Investigational Site 0235)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Honolulu : GSK Investigational Site

Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects

Honolulu : OnCare Hawaii, Incorporated - Lusitana

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

View More »

Honolulu : Tripler Army Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Honolulu : Kapiolani Medical Center for Women and Children

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Honolulu : Cancer Research Center of Hawaii

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Honolulu : Straub Clinic and Hospital, Incorporated

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Honolulu : OnCare Hawaii, Incorporated - Kuakini

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Honolulu : Hawaii Medical Center - East

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Honolulu : Queen's Cancer Institute at Queen's Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Honolulu : University of Hawaii Updated

S0820, Adenoma and Second Primary Prevention Trial

Honolulu : Kaiser Permanente Moanalua Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Honolulu : Queen's Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Honolulu : Oncare Hawaii Inc-Kuakini Updated

S0820, Adenoma and Second Primary Prevention Trial

Honolulu : Hawaii Medical Center East Updated

S0820, Adenoma and Second Primary Prevention Trial

Honolulu : Straub Clinic and Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Honolulu : OnCare Hawaii-Liliha Updated

S0820, Adenoma and Second Primary Prevention Trial

Honolulu : Kapiolani Medical Center for Women and Children Updated

S0820, Adenoma and Second Primary Prevention Trial

Honolulu : Oncare Hawaii Inc-POB II Updated

S0820, Adenoma and Second Primary Prevention Trial

Kailua : Castle Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Lihue : Kauai Medical Clinic

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Lihue : Wilcox Memorial Hospital and Kauai Medical Clinic Updated

S0820, Adenoma and Second Primary Prevention Trial

Wailuku : Maui Memorial Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Wailuku : Pacific Cancer Institute - Maui

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Wailuku : Maui Memorial Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Wailuku : Pacific Cancer Institute of Maui Updated

S0820, Adenoma and Second Primary Prevention Trial

Boise : Mountain States Tumor Institute at St. Luke's Regional Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Boise : Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Boise : Saint Alphonsus Regional Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Coeur d'Alene : North Idaho Urology

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Fruitland : Saint Luke's Mountain States Tumor Institute - Fruitland

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

View More »

Lewiston : St. Joseph Regional Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Lewiston : Saint Joseph Regional Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Meridian : Mountain States Tumor Institute - Meridian

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Nampa : Saint Luke's Mountain States Tumor Institute

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Twin Falls : Mountain States Tumor Institute at St. Luke's

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Aurora : Rush-Copley Cancer Care Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Bartlett : St. Alexius Breast Care of St. Alexius Medical Center

A Multicenter "Ablate and Resect" Study of Novilase® Interstitial Laser Therapy for the Ablation of Small Breast Cancers

Bloomington : Saint Joseph Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Bloomington% : Illinois CancerCare-Bloomington Updated

S0820, Adenoma and Second Primary Prevention Trial

Canton : Illinois CancerCare-Canton Updated

S0820, Adenoma and Second Primary Prevention Trial

View More »

Carbondale : Memorial Hospital of Carbondale

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Carthage : Illinois CancerCare-Carthage Updated

S0820, Adenoma and Second Primary Prevention Trial

Centralia :

Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer

Chicago : University of Chicago Comprehensive Cancer Center

A Phase 1 Dose Escalation Trial of ASG-5ME in Pancreatic or Gastric Adenocarcinoma

Chicago : University of Chicago Medical Center, Site #001

A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113

Chicago : Robert Lurie Comprehensive Cancer Center of Northwestern University

A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer

Chicago : Pfizer Investigational Site

A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer

Chicago :

A Study of RO5185426 (Vemurafenib) in Patients With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation

Chicago : Pfizer Investigational Site

A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer

Chicago : Call for Information (Investigational Site 0024)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Chicago : Call for Information (Investigational Site 0454)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Chicago : Call for Information (Investigational Site 0023)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Chicago : Site Reference ID/Investigator# 26525

ABT-348 as Monotherapy or Combination With Carboplatin or Docetaxel to Treat Advanced Solid Tumors

Chicago : GSK Investigational Site Updated

ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D

Chicago : Center for Women

An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+

Chicago : The University of Chicago Medical Center

Clinical Study of WT2725 in Patients With Advanced Solid Malignancies

Chicago : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Chicago : Northwestern Memorial Hospital Updated

Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer

Chicago : Research Site

EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer

Chicago : University of IL at Chicago Updated

Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction

Chicago : Call for Information (Investigational Site 0230)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Chicago : Investigational Site Number 840014 Updated

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

Chicago : Loyola University Medical Center

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

Chicago : John H. Stroger, Jr. Hospital of Cook County

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Chicago : Louis A. Weiss Memorial Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Chicago : Weiss Memorial Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Chicago : Site Reference ID/Investigator# 66110

Study of ABT-700 in Subjects With Advanced Solid Tumors

Chicago : Univeristy of Chicago

Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma)

Chicago :

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

Chicago : Call for Information (Investigational Site 0004) Updated

Study of MK-3475 in Participants With Advanced Solid Tumors (MK-3475-012)

Decatur : Call for Information (Investigational Site 0285)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Decatur : Decatur Memorial Hospital Cancer Care Institute

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Decatur : Decatur Memorial Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Decatur : Investigational Site Number 840017

Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment

Elgin : Sherman Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Eureka : Illinois CancerCare-Eureka Updated

S0820, Adenoma and Second Primary Prevention Trial

Evanston :

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Evanston : NorthShore University HealthSystem

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer

Evanston : Evanston Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Galesburg :

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Galesburg : Galesburg Clinic Updated

S0820, Adenoma and Second Primary Prevention Trial

Galesburg :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Geneva : Delnor Hospital - Geneva

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Glenview :

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Gurnee :

Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer

Harvey : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic Cancer

Harvey : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Harvey : 1200.43.00113 Boehringer Ingelheim Investigational Site Updated

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Harvey : 1200.131.00191 Boehringer Ingelheim Investigational Site Updated

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Harvey : Ingalls Memorial Hospital

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

Hines : Veterans Affairs Medical Center - Hines

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Hines : Hines Veterans Administration Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Joliet : Joliet Oncology-Hematology Associates, Ltd. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Joliet : Call for Information (Investigational Site 0407)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Joliet : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Kankakee : Urological Suregons of Illinois Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Kewanee : Illinois CancerCare-Kewanee Clinic Updated

S0820, Adenoma and Second Primary Prevention Trial

Macomb : Illinois CancerCare-Macomb Updated

S0820, Adenoma and Second Primary Prevention Trial

Maywood : Loyola University Chicago, Loyola University Medical Center Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Maywood : Call for Information (Investigational Site 0273)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Maywood : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Maywood : Cardinal Bernardin Cancer Center at Loyola University Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Maywood : Loyola University Medical Center, Cardinal Bernardin Cancer Center

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Maywood : Loyola University Medical Center

Umbilical Cord Transplantation for the Elderly Population

Melrose Park : UroPartners/RMD Clinical Research

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Melrose Park :

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Moline :

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Moline : Trinity Cancer Center at Trinity Medical Center - 7th Street Campus

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Monmouth : Holy Family Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Monmouth : Illinois CancerCare-Monmouth Updated

S0820, Adenoma and Second Primary Prevention Trial

Mount Vernon : Good Samaritan Regional Health Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Naperville : DuPage Medical Group

Use of the Epidermal Micrografts for Wound Healing After Mohs or Excisional Surgery for Skin Cancer

Niles : Oncology Specialists, S.C. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Niles : Call for Information (Investigational Site 0018)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Niles : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Niles :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Normal : Mid-Illinois Hematology & Oncology Associates, LTD Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Normal : Community Cancer Center Foundation Updated

S0820, Adenoma and Second Primary Prevention Trial

Ottawa : Ottawa Regional Hospital and Healthcare Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Ottawa : Illinois CancerCare-Ottawa Clinic Updated

S0820, Adenoma and Second Primary Prevention Trial

Park Ridge : Oncology Specialists, S.C. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Pekin : Illinois CancerCare-Pekin Updated

S0820, Adenoma and Second Primary Prevention Trial

Pekin : Pekin Cancer Treatment Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Peoria : Call for Information (Investigational Site 0277)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Peoria : 1200.43.00106 Boehringer Ingelheim Investigational Site Updated

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Peoria : Methodist Medical Center of Illinois Updated

S0820, Adenoma and Second Primary Prevention Trial

Peoria : Proctor Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Peoria : Illinois CancerCare-Peoria Updated

S0820, Adenoma and Second Primary Prevention Trial

Peoria : OSF Saint Francis Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Peoria : Illinois Oncology Research Association CCOP Updated

S0820, Adenoma and Second Primary Prevention Trial

Peru : Illinois Valley Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Peru : Illinois CancerCare-Peru Updated

S0820, Adenoma and Second Primary Prevention Trial

Princeton : Illinois CancerCare-Princeton Updated

S0820, Adenoma and Second Primary Prevention Trial

River Forest : West Suburban Center for Cancer Care

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Rockford : Call for Information (Investigational Site 0443)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Skokie : Call for Information (Investigational Site 0386)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Skokie : Call for Information (Investigational Site 0303)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Skokie : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Springfield : Springfield Clinic

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Springfield : Southern Illinois University School of Medicine

A Study of the Specificity and Sensitivity of 5- Aminolevulinic Acid (ALA) Fluorescence in Malignant Brain Tumors

Springfield : Regional Cancer Center at Memorial Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Springfield : Memorial Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Urbana : Call for Information (Investigational Site 0205)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Urbana : CCOP - Carle Cancer Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Warrenville : Central Dupage Cancer Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Zion : Midwestern Regional Medical Center Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Anderson : Call for Information (Investigational Site 0025)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Anderson : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Avon : Call for Information (Investigational Site 0257)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Beech Grove : St. Francis Hospital and Health Centers - Beech Grove Campus

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Elkhart : Elkhart Clinic Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

View More »

Elkhart : Elkhart General Hospital Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Elkhart : Elkhart Clinic, LLC

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Elkhart : Michiana Hematology-Oncology, PC - Elkhart

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Elkhart : Elkhart General Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Elkhart : Elkhart General Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Elkhart : Elkhart Clinic Updated

S0820, Adenoma and Second Primary Prevention Trial

Elkhart : Michiana Hematology Oncology PC-Elkhart Updated

S0820, Adenoma and Second Primary Prevention Trial

Evansville : Urological Associates, Inc. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Evansville : Call for Information (Investigational Site 0011)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Evansville :

Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer

Fort Wayne : Fort Wayne Medical Oncology and Hematology, Inc. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Fort Wayne : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Fort Wayne :

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Indianapolis : Indiana University Melvin and Bren Simon Cancer Center

A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion in Patients With Solid Tumors

Indianapolis : Updated

A Multiple-Ascending-Dose Study of the Safety and Tolerability of REGN421(SAR153192) in Patients With Advanced Solid Malignancies

Indianapolis : Indiana University

A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors

Indianapolis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of Anti-VEGFR-3 Monoclonal Antibody IMC-3C5 in Subjects With Advanced Solid Tumors

Indianapolis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Indianapolis : Call for Information (Investigational Site 0427)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Indianapolis : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Indianapolis :

Dose Escalation Study of MLN0128 in Subjects With Advanced Malignancies

Indianapolis : Indiana University School of Medicine Updated

Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer

Indianapolis : Quality Oncology Care, Inc.

Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes

Indianapolis : Community Regional Cancer Center-Community Hospital North

Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes

Indianapolis : Call for Information (Investigational Site 0233)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Indianapolis : IUPUI

Phase 1 Pharmacokinetics Study of Oral MLN9708 in Patients With Advanced Nonhematologic Malignancies or Lymphoma

Indianapolis : Franciscan St. Francis Health Updated

S0820, Adenoma and Second Primary Prevention Trial

Indianapolis : Investigational Site Number 840022

Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment

Indianapolis : Indiana University Cancer Center

Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of Urelumab (BMS-663513) in Subjects With Advanced and/or Metastatic Solid Tumors and Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

Indianapolis : Indiana University Simon Cancer Center

Study of BMN 673, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors

Indianapolis :

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

Indianapolis : Indiana University Melvin and Bren Simon Cancer Center

Study of RAD001 + AMG479 for Patients With Advanced Solid Tumors

Indianapolis : Indiana University Simon Cancer Center

Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated

Jeffersonville : First Urology PSC

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Jeffersonville : Metropolitan Urology Clinical Research Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Jeffersonville : Metropolitan Urology Clinical Research

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Jeffersonville :

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Kokomo : Call for Information (Investigational Site 0442)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Kokomo : Howard Community Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Kokomo : Community Howard Regional Health Updated

S0820, Adenoma and Second Primary Prevention Trial

La Porte : Indiana University Health La Porte Hospital Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

La Porte : Center for Cancer Therapy at LaPorte Hospital and Health Services

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

La Porte : Indiana University Health La Porte Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Lafayette : Horizon Oncology Center

A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)

Lafayette : Research Site

A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumor

Lafayette : Horizon Oncology Research, Inc.

Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment

Martinsville : Morgan Hospital and Medical Center

Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes

Michigan City : Saint Anthony Memorial Health Centers

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Mishawaka : Saint Joseph Regional Medical Center Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Mishawaka : Michiana Hematology-Oncology, PC - South Bend

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Mishawaka : Saint Joseph Regional Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Mishawaka : Saint Joseph Regional Medical Center-Mishawaka Updated

S0820, Adenoma and Second Primary Prevention Trial

Mishawaka : Michiana Hematology Oncology PC-Mishawaka Updated

S0820, Adenoma and Second Primary Prevention Trial

New Albany : Call for Information (Investigational Site 0396)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Plymouth : Michiana Hematology Oncology, P. C. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Plymouth : Michiana Hematology Oncology PC - Plymouth

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Plymouth : Michiana Hematology Oncology PC-Plymouth Updated

S0820, Adenoma and Second Primary Prevention Trial

Richmond : Reid Hospital & Health Care Services

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Richmond : Reid Hospital and Health Care Services Updated

S0820, Adenoma and Second Primary Prevention Trial

South Bend : Northern Indiana Cancer Research Consortium

A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer

South Bend : Northern Indiana Cancer Research Consortium, Michiana Hematology Oncology, P.C. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

South Bend : Memorial Hospital of South Bend Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

South Bend : Northern Indiana Cancer Research Consortium

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

South Bend : CCOP - Northern Indiana CR Consortium

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

South Bend : Memorial Hospital of South Bend

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

South Bend : Michiana Hematology Oncology PC-South Bend Updated

S0820, Adenoma and Second Primary Prevention Trial

South Bend : Northern Indiana Cancer Research Consortium Updated

S0820, Adenoma and Second Primary Prevention Trial

South Bend : Memorial Hospital of South Bend Updated

S0820, Adenoma and Second Primary Prevention Trial

Westville : Michiana Hematology Oncology, P. C. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Westville : Michiana Hematology Oncology PC - La Porte

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Westville : Michiana Hematology Oncology-PC Westville Updated

S0820, Adenoma and Second Primary Prevention Trial

Ames : McFarland Clinic, PC Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Ames : Call for Information (Investigational Site 0249)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Ames : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Ames : McFarland Clinic Updated

Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction

Ames : McFarland Clinic, PC

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

View More »

Ames :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Bettendorf :

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Cedar Rapids : Physician's Clinic of Iowa, P.C. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Cedar Rapids : Call for Information (Investigational Site 0286)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Cedar Rapids : Call for Information (Investigational Site 0360)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Cedar Rapids : Cedar Rapids Oncology Associates

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Cedar Rapids : Mercy Regional Cancer Center at Mercy Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Clive : Medical Oncology and Hematology Associates - West Des Moines

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Council Bluffs : Heartland Oncology & Hematology, PLLC Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Davenport : Genesis Regional Cancer Center at Genesis Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Des Moines : Call for Information (Investigational Site 0197)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Des Moines : CCOP - Iowa Oncology Research Association

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Des Moines : John Stoddard Cancer Center at Iowa Methodist Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Des Moines : Mercy Cancer Center at Mercy Medical Center - Des Moines

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Des Moines : John Stoddard Cancer Center at Iowa Lutheran Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Des Moines : Medical Oncology and Hematology Associates at John Stoddard Cancer Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Des Moines : Medical Oncology and Hematology Associates at Mercy Cancer Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Iowa City : University of Iowa Hospitals and Clinics

A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer

Iowa City : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Iowa City : GSK Investigational Site

Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects

Iowa City : GSK Investigational Site

Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects

Iowa City : Holden Comprehensive Cancer Center

Ketogenic Diet With Concurrent Chemoradiation for Pancreatic Cancer

Mason City : Mercy Cancer Center at Mercy Medical Center - North Iowa

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Sioux City : Updated

An Extension (Rollover) Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Malignancies Previously Enrolled in an Antecedent Vemurafenib Protocol

Sioux City : Siouxland Hematology Oncology Associates Updated

Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction

Sioux City : Mercy Medical Center - Sioux City

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Sioux City : Siouxland Hematology-Oncology Associates, LLP

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Sioux City : St. Luke's Regional Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Sioux City : Saint Luke's Regional Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Sioux City : Siouxland Hematology Oncology Associates Updated

S0820, Adenoma and Second Primary Prevention Trial

Sioux City : Mercy Medical Center-Sioux City Updated

S0820, Adenoma and Second Primary Prevention Trial

Sioux City :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Waterloo : Call for Information (Investigational Site 0382)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Waterloo : Covenant Medical Center

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

West Des Moines : The Iowa Clinic, PC Iowa Urology

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

West Des Moines : The Iowa Clinic

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Chanute : Cancer Center of Kansas, PA - Chanute

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Chanute : Cancer Center of Kansas - Chanute Updated

S0820, Adenoma and Second Primary Prevention Trial

Dodge City : Cancer Center of Kansas, PA - Dodge City

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Dodge City : Cancer Center of Kansas - Dodge City Updated

S0820, Adenoma and Second Primary Prevention Trial

El Dorado : Cancer Center of Kansas, PA - El Dorado

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

View More »

El Dorado : Cancer Center of Kansas - El Dorado Updated

S0820, Adenoma and Second Primary Prevention Trial

Fairway : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study in Head and Neck Cancer

Fairway : University of Kansas Cancer Center

A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer

Fairway : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Study in Head and Neck Cancer

Fort Scott : Cancer Center of Kansas - Fort Scott

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Fort Scott : Cancer Center of Kansas - Fort Scott Updated

S0820, Adenoma and Second Primary Prevention Trial

Great Bend : Saint Rose Ambulatory and Surgery Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Hays : Hays Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Hutchinson : Promise Regional Medical Center-Hutchinson Updated

S0820, Adenoma and Second Primary Prevention Trial

Independence : Cancer Center of Kansas-Independence

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Independence : Cancer Center of Kansas-Independence Updated

S0820, Adenoma and Second Primary Prevention Trial

Kansas City : University of Kansas Cancer Center Medical Center

Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors

Kansas City : Investigational Site Number 840001 Updated

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

Kansas City : Kansas City Cancer Center-West Updated

S0820, Adenoma and Second Primary Prevention Trial

Kansas City : University of Kansas Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Kansas City :

Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer

Kingman : Cancer Center of Kansas, PA - Kingman

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Kingman : Cancer Center of Kansas-Kingman Updated

S0820, Adenoma and Second Primary Prevention Trial

Lawrence : Lawrence Memorial Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Lawrence : Lawrence Memorial Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Liberal : Cancer Center of Kansas, PA - Liberal

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Liberal : Cancer Center of Kansas-Liberal Updated

S0820, Adenoma and Second Primary Prevention Trial

McPherson : Cancer Center of Kansas, PA - McPherson

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

McPherson : Cancer Center of Kansas - McPherson Updated

S0820, Adenoma and Second Primary Prevention Trial

Newton : Cancer Center of Kansas, PA - Newton

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Newton : Cancer Center of Kansas - Newton Updated

S0820, Adenoma and Second Primary Prevention Trial

Overland Park : Kansas City Urology Care Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Overland Park : Menorah Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Overland Park : Saint Luke's Hospital - South

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Overland Park : Kansas City Cancer Centers-Southwest Updated

S0820, Adenoma and Second Primary Prevention Trial

Parsons : Cancer Center of Kansas, PA - Parsons

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Parsons : Cancer Center of Kansas - Parsons Updated

S0820, Adenoma and Second Primary Prevention Trial

Pittsburg : Via Christi Hospital-Pittsburg Updated

S0820, Adenoma and Second Primary Prevention Trial

Prairie Village : CCOP - Kansas City

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Pratt : Cancer Center of Kansas, PA - Pratt

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Pratt : Cancer Center of Kansas - Pratt Updated

S0820, Adenoma and Second Primary Prevention Trial

Salina : Cancer Center of Kansas, PA - Salina

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Salina : Tammy Walker Cancer Center at Salina Regional Health Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Salina : Salina Regional Health Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Salina : Cancer Center of Kansas - Salina Updated

S0820, Adenoma and Second Primary Prevention Trial

Topeka : Cotton-O'Neil Cancer Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Topeka : Saint Francis Hospital and Medical Center - Topeka Updated

S0820, Adenoma and Second Primary Prevention Trial

Wellington : Cancer Center of Kansas, PA - Wellington

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Wellington : Cancer Center of Kansas - Wellington Updated

S0820, Adenoma and Second Primary Prevention Trial

Westwood : University of Kansas Cancer Center Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Westwood : University of Kansas Medical Center

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Westwood :

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

Wichita : Cancer Center of Kansas Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Wichita : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Wichita : Call for Information (Investigational Site 0199)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Wichita : GSK Investigational Site

Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects

Wichita : Cancer Center of Kansas, PA - Medical Arts Tower

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Wichita : Cancer Center of Kansas, PA - Wichita

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Wichita : Via Christi Cancer Center at Via Christi Regional Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Wichita : Associates in Womens Health, PA - North Review

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Wichita : CCOP - Wichita

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Wichita : Via Christi Regional Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Wichita : Associates In Womens Health Updated

S0820, Adenoma and Second Primary Prevention Trial

Wichita : Cancer Center of Kansas-Wichita Medical Arts Tower Updated

S0820, Adenoma and Second Primary Prevention Trial

Wichita : Wichita CCOP Updated

S0820, Adenoma and Second Primary Prevention Trial

Wichita : Cancer Center of Kansas - Main Office Updated

S0820, Adenoma and Second Primary Prevention Trial

Wichita : GSK Investigational Site

Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study

Wichita :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Winfield : Cancer Center of Kansas, PA - Winfield

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Winfield : Cancer Center of Kansas - Winfield Updated

S0820, Adenoma and Second Primary Prevention Trial

Ashland :

Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer

Bardstown : Call for Information (Investigational Site 0228)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Hazard :

A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

Hazard :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Lexington : University of Kentucky Updated

S0820, Adenoma and Second Primary Prevention Trial

View More »

Lexington : University of Kentucky

Tracking Renal Tumors After Cryoablation Evaluation

Louisville : Owlsey Brown Frazier Cancer Center Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Louisville : CBC/Baptist Hospital East

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer

Louisville : University of Louisville James Brown Cancer Center

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer

Louisville :

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

Louisville :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Paducah : Call for Information (Investigational Site 0283)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Paducah : Call for Information (Investigational Site 0269)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Paducah : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Baton Rouge : Ochsner Clinic - Baton Rouge Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Baton Rouge : Ochsner Health Center - Bluebonnet

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Bossier City :

Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

Bossier City :

Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer

Covington : Pfizer Investigational Site

A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer

View More »

Covington : Call for Information (Investigational Site 0310)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Covington : Ochsner Health Center - Covington

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Crowley : Louisiana Oncology Associates Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Lafayette : Louisiana Oncology Associates Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Marrero :

A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

Marrero : Call for Information (Investigational Site 0249)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Metairie : Call for Information (Investigational Site 0275)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Metairie : Investigational Site Number 840003

Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment

Monroe : Louisiana State University Health Sciences Center - Monroe

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Monroe : Louisiana State University Sciences Center- Monroe Updated

S0820, Adenoma and Second Primary Prevention Trial

New Iberia : Louisiana Oncology Associates Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

New Orleans : Ochsner Cancer Institute

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

New Orleans : Tulane University

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

New Orleans : Ochsner Clinic Foundation Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

New Orleans : Tulane University Health Sciences Center Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

New Orleans : Ochsner Clinic Foundation

A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)

New Orleans : Call for Information (Investigational Site 0200)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

New Orleans : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

New Orleans : Research Site

EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer

New Orleans :

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

New Orleans : 1200.131.00187 Boehringer Ingelheim Investigational Site Updated

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

New Orleans : CCOP - Ochsner

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

New Orleans : Ochsner Cancer Institute at Ochsner Clinic Foundation

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

New Orleans : Tulane University Medical School

Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer

Opelousas : Louisiana Oncology Associates Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Shreveport : Northwest Louisiana Oncology Associates Of Highland Clinic Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Shreveport : Regional Urology, LLC Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Shreveport :

Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

Shreveport : Highland Clinic

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Shreveport : Feist-Weiller Cancer Center at Louisiana State University Health Sciences

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Shreveport : Highland Clinic Updated

S0820, Adenoma and Second Primary Prevention Trial

Shreveport : Louisiana State University Updated

S0820, Adenoma and Second Primary Prevention Trial

Shreveport :

Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer

Lewiston : Call for Information (Investigational Site 0293)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Scarborough : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Annapolis : Call for Information (Investigational Site 0397)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Baltimore : Research Site

A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors

Baltimore : Greater Baltimore Medical Center

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Baltimore : Union Memorial Hospital

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Baltimore : Chesapeake Urology Research Associates Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

View More »

Baltimore : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Baltimore : University of Maryland Greenebaum Cancer Center

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Baltimore :

A Study of RO5185426 (Vemurafenib) in Patients With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation

Baltimore :

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Baltimore : The Sidney Kimmel Comprehensive Cancer Center

A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Castration-Resistant Prostate Cancer

Baltimore : Research Site

A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumor

Baltimore : Call for Information (Investigational Site 0318)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Baltimore : Call for Information (Investigational Site 0247)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Baltimore : Call for Information (Investigational Site 0400)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Baltimore : Call for Information (Investigational Site 0302)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Baltimore : Sidney Kimmel Cancer Center @ Johns Hopkins

A Trial of Oral 5-azacitidine in Combination With Romidepsin in Advanced Solid Tumors, With an Expansion Cohort in Non-small Cell Lung Cancer

Baltimore : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Baltimore : Investigational Site Number 840002 Updated

Early Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Baltimore : The Johns Hopkins Hospital Updated

Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer

Baltimore : 1200.131.00173 Boehringer Ingelheim Investigational Site Updated

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Baltimore : Investigational Site Number 840013 Updated

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

Baltimore : Mercy Medical Center

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

Baltimore : MedStar Harbor Hospital

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

Baltimore : Lifebridge Health

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

Baltimore : Harry & Jeanette Weinberg Cancer Institute at Franklin Square

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

Baltimore : Sinai Hospital of Baltimore Updated

S0820, Adenoma and Second Primary Prevention Trial

Baltimore : Investigational Site Number 840019

Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment

Baltimore : Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

Safety Study of IL-21/Anti-PD-1 Combination in the Treatment of Solid Tumors

Baltimore : Johns Hopkins Hospital

Screening for Early Pancreatic Neoplasia (Cancer of the Pancreas Screening or CAPS4 Study)

Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Study Determining the Safety and Tolerability of Combination Therapy With Pazopanib and GSK1120212 in Advanced Solid Tumors Enriched With Patients With Advanced Differentiated Thyroid Cancer

Baltimore :

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

Baltimore :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Baltimore : University of Maryland Marlene & Stewart Greenebaum Cancer Center

Study of How Well Letrozole Works in Combination With Lapatinib Followed by an Addition of Everolimus in Postmenopausal Women With Advanced Endocrine Resistant Breast Cancer

Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Study of Intravenous TCD-717 in Patients With Advanced Solid Tumors

Baltimore :

Study of the Safety and Pharmacokinetics of MPDL3280A Administered Intravenously As a Single Agent to Patients With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies

Bethesda : National Cancer Institute - Center for Cancer Research

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Bethesda : Walter Reed Army Medical Center

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Bethesda : Call for Information (Investigational Site 0012)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Bethesda : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Bethesda : Investigational Site Number 840007 Updated

Early Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Bethesda : Center for Cancer and Blood Disorders

Melphalan and Panobinostat in Treating Patients With Recurrent Multiple Myeloma

Bethesda : NCI, CCR Updated

Open Label Study to Evaluate the Safety and Tolerability of GI-6301 (Whole Heat-Killed Recombinant Yeast Modified to Express Brachyury Protein) in Adults With Solid Tumors

Bethesda :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Bethesda : Bethesda Naval Medical Center

The Study of Barrett's Esophagus: What Are the Factors of Progression

Chevy Chase : Chevy Chase Clinical Research Updated

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

Cumberland : Western Maryland Health System

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

Elkridge : Call for Information (Investigational Site 0242)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Elkton : Union Hospital of Cecil County

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Frederick : Call for Information (Investigational Site 0279)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Greenbelt : Myron Murdock M.D. LLC

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Greenbelt : Myron I Murdock MD LLC Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Greenbelt : Myron I. Murdock MD, LLC

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Rockville :

An Extension Study of RO5045337 in Patients Participating in Previous Cancer Studies

Rockville :

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Towson :

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Towson :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Westminster : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Boston : Call for Information (Investigational Site 0003)

A Dose Escalation Study of MK1775 in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001 AM7)

Boston : Updated

A Multiple-Ascending-Dose Study of the Safety and Tolerability of REGN421(SAR153192) in Patients With Advanced Solid Malignancies

Boston : Dana-Farber Cancer Institute

A Phase 1 Dose Escalation Trial of ASG-5ME in Pancreatic or Gastric Adenocarcinoma

Boston : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician

A Phase 1 Study of LY2835219 In Participants With Advanced Cancer

Boston : Dana Farber Cancer Institute

A Phase 1, Dose Escalation Study to Assess the Safety and Tolerability of ASP9853 With Either Docetaxel or Paclitaxel in Patients With Advanced Non-hematologic Malignancies

View More »

Boston : Mass General Hospital (MGH), Site #047

A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113

Boston : Beth Israel Deaconess Medical Center

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Boston : Dana Farber Cancer Institute

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Boston : Investigational Site Number 840001

A Phase I/Ib Trial for the Evaluation of SAR260301 in Monotherapy or in Combination With Vemurafenib in Patients With Various Advanced Cancer

Boston : Massachusetts General Hospital CCPO

A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid Tumors

Boston : Massachusetts General Hospital Mass General 2

A Phase Ib/II Study of LGX818 in Combination With MEK162 in Adult Patients With BRAF Dependent Advanced Solid Tumors

Boston : Dana-Farber Cancer Institute Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Boston : Tufts Medical Center Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Boston : Steward Sr. Elizabeth's Medical Center of Boston Inc. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Boston : Dana Farber Cancer Institute

A Safety Study of Oral ZSTK474 in Patients With Cancer

Boston : Dana-Farber / BIDMC / Harvard Cancer Center

A Safety, Pharmacokinetic and Pharmacodynamic Study of Kevetrin in Patients With Advanced Solid Tumors

Boston :

A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0973 in Combination With GDC-0068 When Administered in Patients With Locally Advanced or Metastatic Solid Tumors

Boston : Research Site

A Study of AMG 337 in Subjects With Advanced Solid Tumors

Boston : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of Anti-VEGFR-3 Monoclonal Antibody IMC-3C5 in Subjects With Advanced Solid Tumors

Boston : Investigational Site Number 840101

A Study of Investigational SAR256212 in Combination With SAR245408 in Patients With Solid Tumor Cancers

Boston : Investigational Site Number 840001

A Study of Investigational SAR256212 in Combination With SAR245408 in Patients With Solid Tumor Cancers

Boston : Dana Farber Cancer Institute SC

A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumors

Boston : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Boston :

A Study of MPDL3280A in Combination With Avastin (Bevacizumab) or With Avastin Plus Chemotherapy in Patients With Advanced Solid Tumors

Boston : Pfizer Investigational Site

A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer

Boston : Dana-Farber Cancer Institute

A Study of Oral Rucaparib in Patients With gBRCA Mutation Breast or Ovarian Cancer, or Other Solid Tumor

Boston : Dana Farber Cancer Institute

A Study of Oral Sapacitabine and Oral Seliciclib in Patients With Advanced Solid Tumors

Boston :

A Study of RO5185426 (Vemurafenib) in Patients With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation

Boston : Dana-Farber Cancer Institute

A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4

Boston : Pfizer Investigational Site

A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer

Boston :

A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers

Boston : Research Site

A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumor

Boston : Tufts-New England Medical Center

A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies

Boston : Dana Farber Cancer Institute DFCI

A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma

Boston : BWH

An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation

Boston : Investigational Site Number 840002 Updated

Cabazitaxel in Pediatric Patients With Refractory Solid Tumors Including Central Nervous System Tumors

Boston : Dana Farber Cancer Institute Updated

Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors

Boston : Beth Israel Deaconess Medical Center`

Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma

Boston : Dana-Farber Cancer Institute

Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma

Boston : Massachusetts General Hospital

Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma

Boston :

Dose Escalation Study of MLN0128 in Subjects With Advanced Malignancies

Boston : Massachusetts General Hospital / Dana Farber Cancer Institute

E7050 in Combination With E7080 in Subjects With Advanced Solid Tumors (Dose Escalation) and in Subjects With Recurrent Glioblastoma or Unresectable Stage III or Stage IV Melanoma After Prior Systemic Therapy (Expansion Cohort and Phase 2)

Boston : GSK Investigational Site Updated

Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer

Boston : Beth Israel Deaconess Medical Center

Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.

Boston : Dana-Farber Cancer Institute

Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.

Boston : Massachusetts General Hospital

First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IMGN853 in Adults With Ovarian Cancer and Other FOLR1-Positive Solid Tumors

Boston :

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Boston : 1200.43.00110 Boehringer Ingelheim Investigational Site Updated

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Boston : 1200.131.00176 Boehringer Ingelheim Investigational Site Updated

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Boston : 1200.131.00190 Boehringer Ingelheim Investigational Site Updated

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Boston : Dana-Farber Cancer Institute

MSC2015103B in Solid Tumors

Boston : Beth Israel Deaconess Medical Center

MSC2015103B in Solid Tumors

Boston : Dana Farber Cancer Institute Dana SC

Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors

Boston : Investigational Site Number 840012

Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment

Boston : Dana-Farber Cancer Institute

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

Boston : Massachusetts General Hospital Mass General 2

Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients

Boston : Dana Farber Cancer Institute

Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of Urelumab (BMS-663513) in Subjects With Advanced and/or Metastatic Solid Tumors and Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

Boston :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Boston : Call for Information (Investigational Site 0002)

Study of Safety and Pharmacokinetics of MK-8242 in Participants With Advanced Solid Tumors (P07650 AM1)

Boston : Massachusetts General Hospital Cancer Center

Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors

Boston : Beth Israel Deaconess Medical Center (BIDMC) - Cancer Center

Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors

Boston : Dana Farber Cancer Institute

Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors

Boston :

Study of the Safety and Pharmacokinetics of MPDL3280A Administered Intravenously As a Single Agent to Patients With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies

Boston : Massachusetts General Hospital

Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors

Brockton : Commonwealth Clinical Studies Updated

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

Burlington : Lahey Clinic

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

Methuen : Caritas Holy Family Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Methuen :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Rockland : Contact US Medical Information for US Recruiting Sites

MSB0010718C in Solid Tumors

Worcester : St. Vincent Hospital

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

Adrian : Hickman Cancer Center at Bixby Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Ann Arbor : University of Michigan Comprehensive Cancer Center

A Dose Escalation Study of OMP-18R5 in Subjects With Solid Tumors

Ann Arbor : University of Michigan Comprehensive Cancer Center

A Dose Escalation Study of OMP-54F28 in Subjects With Solid Tumors

Ann Arbor : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2875358 in Patients With Advanced Cancer

Ann Arbor : University of Michigan Comprehensive Cancer Center

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

View More »

Ann Arbor : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of Necitumumab Monotherapy and the QT/QTc Interval in Patient With Advanced Solid Tumors

Ann Arbor : University of Michigan Comprehensive Cancer Center SC

A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma

Ann Arbor : University of Michigan Cancer Center

Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas

Ann Arbor : Research Site

EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer

Ann Arbor : Michigan Cancer Research Consortium and Oncology Research- St. Joseph Mercy Hospital - Ann Arbor Updated

Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction

Ann Arbor : Investigational Site Number 840010 Updated

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

Ann Arbor : Saint Joseph Mercy Cancer Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Ann Arbor : CCOP - Michigan Cancer Research Consortium

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Ann Arbor : University of Michigan Comprehensive Cancer Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Ann Arbor : Saint Joseph Mercy Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Ann Arbor : Michigan Cancer Research Consortium Community Clinical Oncology Program Updated

S0820, Adenoma and Second Primary Prevention Trial

Ann Arbor : University of Michigan Health System

Study of BMN 673, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors

Ann Arbor : Investigational Site Number 840010

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Ann Arbor : University of Michigan

Trial of Cabozantinib (XL184) in Castrate-Resistant Prostate Cancer Metastatic to Bone

Battle Creek : Battle Creek Health System Cancer Care Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Battle Creek : Bronson Battle Creek Updated

S0820, Adenoma and Second Primary Prevention Trial

Bay City : Bay Regional Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Big Rapids : Mecosta County Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Big Rapids : Mecosta County Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Brownstown : Henry Ford Medical Center - Woodhaven Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Dearborn : Henry Ford Medical Center - Fairlane Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Dearborn : Pfizer Investigational Site

A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer

Dearborn : Oakwood Cancer Center at Oakwood Hospital and Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Dearborn : Oakwood Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Detroit : Wayne State University/Karmanos Cancer Institute Dept.of KarmanosCancerInst (6)

A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies

Detroit : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Drug-Interaction Study of Necitumumab (IMC-11F8) in Combination With Gemcitabine-Cisplatin

Detroit : Updated

A Multiple-Ascending-Dose Study of the Safety and Tolerability of REGN421(SAR153192) in Patients With Advanced Solid Malignancies

Detroit :

A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction

Detroit : Karmanos Cancer Institute

A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors

Detroit : Barbara Ann Karmanos Cancer Center

A Phase 1, Dose Escalation Study to Assess the Safety and Tolerability of ASP9853 With Either Docetaxel or Paclitaxel in Patients With Advanced Non-hematologic Malignancies

Detroit : Karmanos Cancer Institute

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

Detroit : Henry Ford Hospital Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Detroit : Karmanos Cancer Institute Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Detroit :

A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma

Detroit :

A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0973 in Combination With GDC-0068 When Administered in Patients With Locally Advanced or Metastatic Solid Tumors

Detroit : GSK Investigational Site

A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib

Detroit : Karmanos Cancer Center

A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer

Detroit : Research Site

A Study of AMG 337 in Subjects With Advanced Solid Tumors

Detroit :

A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer

Detroit : Barbara Ann Karmanos Cancer Center

A Study of MGCD265 Given With Erlotinib or Docetaxel in Subjects With Advanced Malignancies or Non-Small Cell Lung Cancer

Detroit : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of Necitumumab Monotherapy and the QT/QTc Interval in Patient With Advanced Solid Tumors

Detroit : Wayne State University/Karmanos Cancer Institute Wayne St

A Study of Oral LGK974 in Patients With Malignancies Dependent on Wnt Ligands

Detroit : Pfizer Investigational Site

A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer

Detroit : Karmanos Cancer Institute

A Study of Oral Rucaparib in Patients With gBRCA Mutation Breast or Ovarian Cancer, or Other Solid Tumor

Detroit : Karmanos Cancer institute

A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4

Detroit : Investigational Site Number 840001

A Study of the Safety and Pharmacokinetics of SAR245409 Tablets in Patients With Solid Tumors or Lymphoma

Detroit :

A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers

Detroit : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study to Assess the Pharmacokinetics of Ramucirumab in Combination With FOLFIRI

Detroit : The Karmanos Cancer Institute

A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Castration-Resistant Prostate Cancer

Detroit : Research Site

A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumor

Detroit : Call for Information (Investigational Site 0229)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Detroit : GSK Investigational Site

Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents

Detroit : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Detroit : Karmanos Cancer Institute Updated

Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer

Detroit : Research Site

EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer

Detroit : Barbara Ann Karmanos Cancer Institute

First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IMGN853 in Adults With Ovarian Cancer and Other FOLR1-Positive Solid Tumors

Detroit : Karmanos Cancer Institute

MSC2015103B in Solid Tumors

Detroit : Investigational Site Number 840001 Updated

Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen

Detroit :

Phase 1 Dose Escalation Study of ARQ 087 in Adult Subjects With Advanced Solid Tumors

Detroit : Detroit Clinical Research Center

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

Detroit : Josephine Ford Cancer Center at Henry Ford Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Detroit : Wayne State University Updated

S0820, Adenoma and Second Primary Prevention Trial

Detroit : Saint John Hospital and Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Detroit : Karmanos Cancer Institute

Safety and Efficacy of Cryoablation for the Palliation of Painful Bone Metastases

Detroit : Wayne State (Karmanos Cancer Institute)

Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration

Detroit : Investigational Site Number 840004

Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment

Detroit : Karmanos Cancer Institute

Safety Study of AB0024 in Patients With Advanced Solid Tumors

Detroit : Wayne State University/Karmanos Cancer Institute Study Coordinator

Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients

Detroit : Site Reference ID/Investigator# 57555

Study of ABT-700 in Subjects With Advanced Solid Tumors

Detroit : Karmanos Cancer Institute

Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma)

Detroit :

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

Detroit :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Detroit : Barbara Ann Karmanos Cancer Institute

Study of Intravenous TCD-717 in Patients With Advanced Solid Tumors

Detroit : Wayne State University/Karmanos Cancer Institute

Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors

Detroit : Karmanos Cancer Center

Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors

Escanaba : Green Bay Oncology, Limited - Escanaba

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Farmington Hills : Karmanos Cancer Institute at Farmington Hills Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Flint : Singh and Arora Hematology Oncology, PC

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Flint : Genesys Hurley Cancer Institute

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Flint : Hurley Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Flint : McLaren Cancer Institute

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Flint : Hurley Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Flint : Genesys Hurley Cancer Institute Updated

S0820, Adenoma and Second Primary Prevention Trial

Grand Rapids : Spectrum Health Medical Group

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Grand Rapids : Call for Information (Investigational Site 0423)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Grand Rapids : Spectrum Health / Advanced Radiology Services Updated

Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer

Grand Rapids : CCOP - Grand Rapids

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Grand Rapids : Butterworth Hospital at Spectrum Health

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Grand Rapids : Lacks Cancer Center at Saint Mary's Health Care

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Grand Rapids : Saint Mary's Health Care Updated

S0820, Adenoma and Second Primary Prevention Trial

Grand Rapids : Grand Rapids Clinical Oncology Program Updated

S0820, Adenoma and Second Primary Prevention Trial

Grand Rapids : Spectrum Health at Butterworth Campus Updated

S0820, Adenoma and Second Primary Prevention Trial

Grosse Pointe Woods : Van Elslander Cancer Center at St. John Hospital and Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Iron Mountain : Dickinson County Healthcare System

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Jackson : Foote Memorial Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Jackson : Allegiance Health Updated

S0820, Adenoma and Second Primary Prevention Trial

Kalamazoo : West Michigan Cancer Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Kalamazoo : Borgess Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Kalamazoo : Bronson Methodist Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Lansing : Call for Information (Investigational Site 0383)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Lansing :

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Lansing : Sparrow Regional Cancer Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Lansing : Breslin Cancer Center at Ingham Regional Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Lansing : Sparrow Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Lapeer : Great Lakes Cancer Institute - Lapeer Campus

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Livonia : St. Mary Mercy Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Livonia : Saint Mary Mercy Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Monroe : Mercy Memorial Hospital - Monroe

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Monroe : Community Cancer Center of Monroe

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Mount Clemens : Clemens Regional Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Muskegon : Mercy General Health Partners

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Muskegon : Mercy Health Partners-Mercy Campus Updated

S0820, Adenoma and Second Primary Prevention Trial

Niles : Lakeland Hospital Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Novi : Henry Ford Medical Center - Columbus Center Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Petoskey : Northern Michigan Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Pontiac : St. Joseph Mercy Oakland

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Pontiac : Saint Joseph Mercy Oakland Updated

S0820, Adenoma and Second Primary Prevention Trial

Port Huron : Mercy Regional Cancer Center at Mercy Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Port Huron : Saint Joseph Mercy Port Huron Updated

S0820, Adenoma and Second Primary Prevention Trial

Reed City : Spectrum Health Reed City Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Royal Oak : William Beaumont Hospital - Royal Oak Campus

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Saginaw :

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Saginaw : Seton Cancer Institute at Saint Mary's - Saginaw

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Saginaw : Saint Mary's of Michigan Updated

S0820, Adenoma and Second Primary Prevention Trial

Southfield : Pfizer Investigational Site

A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer

Southfield : Providence Cancer Institute at Providence Hospital - Southfield Campus

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

St. Clair Shores : Michgan Institute of Urology, PC Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

St. Joseph : Marie Yeager Cancer Center Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

St. Joseph : Lakeland Hospital Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

St. Joseph : Lakeland Regional Cancer Care Center - St. Joseph

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

St. Joseph : Lakeside Cancer Specialists, PLLC

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

St. Joseph : Lakeland Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

St. Joseph : Marie Yeager Cancer Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Traverse City : Munson Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Traverse City : Munson Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Troy : Michigan Institute of Urology, PC Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Utica : Michigan Institute of Urology, PC Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Warren : Pfizer Investigational Site

A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer

Warren : St. John Macomb Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Warren : Saint John Macomb-Oakland Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

West Bloomfield : Henry Ford Medical Center- West Bloomfield Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Wyoming :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Brainerd : St. Joseph's Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Burnsville : Minnesota Oncology Hematology, P.A. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Burnsville : Fairview Ridges Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Burnsville : Fairview Ridges Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Coon Rapids : Minnesota Oncology Hematology, P.A. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

View More »

Coon Rapids : Mercy and Unity Cancer Center at Mercy Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Coon Rapids : Mercy Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Duluth : Call for Information (Investigational Site 0282)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Duluth : Miller - Dwan Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Duluth : CCOP - Duluth

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Duluth : Duluth Clinic Cancer Center - Duluth

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Edina : Minnesota Oncology Hematology, P.A. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Edina : Fairview Southdale Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Edina : Fairview-Southdale Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Fridley : Minnesota Oncology Hematology, P.A. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Fridley : Mercy and Unity Cancer Center at Unity Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Fridley : Unity Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Hutchinson : Hutchinson Area Health Care

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Hutchinson : Hutchinson Area Health Care Updated

S0820, Adenoma and Second Primary Prevention Trial

Maplewood : Minnesota Oncology Hematology, P.A. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Maplewood : HealthEast Cancer Care at St. John's Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Maplewood : Minnesota Oncology - Maplewood

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Maplewood : Saint John's Hospital - Healtheast Updated

S0820, Adenoma and Second Primary Prevention Trial

Maplewood : Minnesota Oncology Hematology PA-Maplewood Updated

S0820, Adenoma and Second Primary Prevention Trial

Minneapolis : University Of Minnesota Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Minneapolis : Minnesota Oncology Hematology, P.A. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Minneapolis : University of Minnesota

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Minneapolis : Call for Information (Investigational Site 0022)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Minneapolis : Research Site

Panitumumab Pediatric Study

Minneapolis : Virginia Piper Cancer Institute

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

Minneapolis : Hennepin County Medical Center - Minneapolis

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Minneapolis : Virginia Piper Cancer Institute at Abbott - Northwestern Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Minneapolis : Abbott-Northwestern Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Minneapolis : Hennepin County Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Minneapolis : Novartis Investigative Site

Safety and Tolerability of HSC835 in Patients With Hematological Malignancies

Minneapolis : University of Minnesota: Masonic Cancer Center, BMT Clinic, and Fairview Medical Center

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Minneapolis :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

New Ulm : New Ulm Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

New Ulm : New Ulm Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Robbinsdale : Hubert H. Humphrey Cancer Center Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Robbinsdale : Humphrey Cancer Center at North Memorial Outpatient Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Robbinsdale : North Memorial Medical Health Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Rochester : Mayo Clinic

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Rochester : Mayo Clinic

A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers

Rochester : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2875358 in Patients With Advanced Cancer

Rochester : Mayo Clinic

Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas

Rochester : Mayo Clinic Cancer Center Updated

Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer

Rochester : Mayo Clinic Updated

Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction

Rochester :

Phase 1 Study of PI3 (Phosphatidylinositol-3)-Kinase Inhibitor BAY80-6946 With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer

Rochester : Mayo Clinic - Rochester Division of Hematology

Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors

Rochester : Investigational Site Number 840007

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Saint Paul : United Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Saint Paul : Regions Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Saint Paul : United Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Sartell : Adult and Pediatric Urology Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Shakopee : St. Francis Cancer Center at St. Francis Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Shakopee : Saint Francis Regional Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

St. Cloud : Call for Information (Investigational Site 0202)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

St. Louis Park : Metro MN CCOP Updated

Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction

St. Louis Park : Park Nicollet Cancer Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

St. Louis Park : CCOP - Metro-Minnesota

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

St. Louis Park : Park Nicollet Clinic - Saint Louis Park Updated

S0820, Adenoma and Second Primary Prevention Trial

St. Louis Park : Metro-Minnesota CCOP Updated

S0820, Adenoma and Second Primary Prevention Trial

St. Paul : Minnesota Oncology Hematology, P.A. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

St. Paul : Regions Hospital Cancer Care Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Stillwater : Lakeview Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Stillwater : Lakeview Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Waconia : Ridgeview Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Waconia : Ridgeview Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Willmar : Willmar Cancer Center at Rice Memorial Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Willmar : Rice Memorial Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Woodbury : Minnesota Oncology Hematology, P.A. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Woodbury :

A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment Into Clinical Research Studies of Zelboraf (Vemurafenib)

Woodbury : Minnesota Oncology - Woodbury

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Woodbury : Minnesota Oncology and Hematology PA-Woodbury Updated

S0820, Adenoma and Second Primary Prevention Trial

Jackson : University of Mississippi Cancer Clinic

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Jackson : Veterans Affairs Medical Center - Jackson

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Jackson : University of Mississippi Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Jackson :

Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer

New Albany : The Jones Clinic, PC Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

View More »

Oxford : Family Cancer Center Foundation, Inc. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Pascagoula : Regional Cancer Center at Singing River Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Pascagoula : Singing River Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Southaven : Family Cancer Center Foundation, Inc. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Bridgeton : St. Louis Cancer Care, LLP Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Cape Girardeau : Southeast Cancer Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Cape Girardeau : Saint Francis Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Chesterfield : St. Louis Cancer Care, LLP Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Columbia : Ellis Fischel Cancer Center - University of Missouri Health Care Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

View More »

Columbia :

A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment Into Clinical Research Studies of Zelboraf (Vemurafenib)

Jefferson City : Goldschmidt Cancer Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Jefferson City :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Kansas City : Kansas City VA Medical Center

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Kansas City : Saint Luke's Cancer Institute, Saint Luke's Hospital Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Kansas City : Children's Mercy Hospital & Clinics Updated

Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors

Kansas City :

Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

Kansas City : Call for Information (Investigational Site 0229)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Kansas City : Heartland Hematology Oncology Associates, Incorporated

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Kansas City : Saint Luke's Cancer Institute at Saint Luke's Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Kansas City : Research Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Kansas City : North Kansas City Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Kansas City : Veterans Affairs Medical Center - Kansas City

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Kansas City : Kansas City Cancer Center - South Updated

S0820, Adenoma and Second Primary Prevention Trial

Kansas City : Truman Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Kansas City : Kansas City Cancer Centers - North Updated

S0820, Adenoma and Second Primary Prevention Trial

Kansas City : Department of Veterans Affairs Medical Center

The Study of Barrett's Esophagus: What Are the Factors of Progression

Lee's Summit : Saint Luke's East - Lee's Summit

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Lee's Summit : Kansas City Cancer Center-Lee's Summit Updated

S0820, Adenoma and Second Primary Prevention Trial

Liberty : Parvin Radiation Oncology

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Mexico : Center for Digestive and Liver Diseases, Inc Updated

Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease

Springfield : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Springfield : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Springfield : Cox Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Springfield : Ozark Health Ventures LLC dba Cancer Research for The Ozarks Springfield Updated

S0820, Adenoma and Second Primary Prevention Trial

Springfield :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

St. Joseph : Saint Joseph Oncology, Incorporated

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

St. Joseph : Heartland Regional Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

St. Louis : Investigational Site Number 840007

A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors

St. Louis : Updated

A Multiple-Ascending-Dose Study of the Safety and Tolerability of REGN421(SAR153192) in Patients With Advanced Solid Malignancies

St. Louis : Siteman Cancer Center, Washington University School of Medicine

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

St. Louis : St. Louis Cancer Care, LLP Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

St. Louis : Comprehensive Cancer Care Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

St. Louis : Washington University

A Safety Study of Oral ZSTK474 in Patients With Cancer

St. Louis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

St. Louis :

A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers

St. Louis : Call for Information (Investigational Site 0150)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

St. Louis : Call for Information (Investigational Site 0294)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

St. Louis : Pfizer Investigational Site

An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)

St. Louis : Washington University School Of Medicine-Siteman Cancer Ctr Wash Uni

Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors

St. Louis : Washington University Updated

Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer

St. Louis : Washington University School of Medicine, Siteman Cancer Center

Open-label, Single Arm, Tumor Imaging and Dosimetry Study of I-124 PGN650 in Advanced Solid Tumors

St. Louis : Updated

Phase I Study of PI3(Phosphoinositol 3)-Kinase Inhibitor BAY80-6946 With Paclitaxel in Patients With Advanced Cancer

St. Louis : SSM Cancer Center

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

St. Louis : CCOP - St. Louis-Cape Girardeau

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

St. Louis : Christian Hospital Northeast Cancer Care Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

St. Louis : Midwest Hematology Oncology Group, Incorporated

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

St. Louis : Saint Louis University Cancer Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

St. Louis : Missouri Baptist Cancer Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

St. Louis : David C. Pratt Cancer Center at St. John's Mercy

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

St. Louis : Investigational Site Number 840001

Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment

St. Louis :

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

St. Louis :

Study of KB004 in Subjects With Hematologic Malignancies

St. Louis : Investigational Site Number 840003

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Billings : Billings Clinic Cancer Center

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Billings : Call for Information (Investigational Site 0368)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Billings : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Billings : Billings Clinic - Downtown

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Billings : St. Vincent Healthcare Cancer Care Services

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

View More »

Billings : Hematology-Oncology Centers of the Northern Rockies - Billings

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Billings : CCOP - Montana Cancer Consortium

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Billings : Billings Clinic Updated

S0820, Adenoma and Second Primary Prevention Trial

Billings : Hematology-Oncology Centers of the Northern Rockies PC Updated

S0820, Adenoma and Second Primary Prevention Trial

Billings : Montana Cancer Consortium CCOP Updated

S0820, Adenoma and Second Primary Prevention Trial

Billings : Saint Vincent Healthcare Updated

S0820, Adenoma and Second Primary Prevention Trial

Bozeman : Bozeman Deaconess Cancer Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Bozeman : Bozeman Deaconess Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Butte : St. James Healthcare Cancer Care

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Butte : Saint James Community Hospital and Cancer Treatment Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Great Falls : Call for Information (Investigational Site 0378)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Great Falls : Sletten Cancer Institute at Benefis Healthcare

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Great Falls : Big Sky Oncology

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Great Falls : Benefis Healthcare- Sletten Cancer Institute Updated

S0820, Adenoma and Second Primary Prevention Trial

Helena : St. Peter's Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Helena : Saint Peter's Community Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Kalispell : Kalispell Medical Oncology at KRMC

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Kalispell : Kalispell Regional Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Kalispell : Kalispell Regional Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Missoula :

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Missoula : Call for Information (Investigational Site 0349)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Missoula : Montana Cancer Center at St. Patrick Hospital and Health Sciences Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Missoula : Montana Cancer Specialists at Montana Cancer Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Missoula : Saint Patrick Hospital - Community Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Missoula : Montana Cancer Specialists Updated

S0820, Adenoma and Second Primary Prevention Trial

Missoula :

Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer

Kearney : Good Samaritan Cancer Center at Good Samaritan Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Kearney : Good Samaritan Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Lincoln : Southeast Nebraska Hematology & Oncology Consultants, PC / Southeast Nebraska Cancer Center Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Lincoln : Nebraska Hematology-Oncology, PC Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Lincoln : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

View More »

Lincoln : Cancer Resource Center - Lincoln

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Lincoln :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Omaha : University of Nebraska Medical Center

A Dose Escalation Study of OMP-52M51 in Subjects With Lymphoid Malignancies

Omaha : Urology Cancer Center and GU Research Network

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

Omaha : GU Research Network, LLC

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Omaha : Oncology Hematology West, PC dba Nebraska Cancer Specialists Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Omaha : Urology Cancer Center & GU Research Network Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Omaha : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Omaha : Call for Information (Investigational Site 0256)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Omaha :

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Omaha : Missouri Valley Cancer Consortium Updated

Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction

Omaha : 1200.43.00107 Boehringer Ingelheim Investigational Site Updated

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Omaha : 1200.131.00182 Boehringer Ingelheim Investigational Site Updated

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Omaha : Lakeside Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Omaha : Immanuel Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Omaha : CCOP - Missouri Valley Cancer Consortium

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Omaha : Alegant Health Cancer Center at Bergan Mercy Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Omaha : Creighton University Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Omaha :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Omaha : University of Nebraska

Tracking Renal Tumors After Cryoablation Evaluation

Henderson : Comprehensive Cancer Centers of Nevada Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Las Vegas : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Drug-Interaction Study of Necitumumab (IMC-11F8) in Combination With Gemcitabine-Cisplatin

Las Vegas : Comprehensive Cancer Centers of Nevada

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Las Vegas : Comprehensive Cancer Centers of Nevada Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Las Vegas :

A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment Into Clinical Research Studies of Zelboraf (Vemurafenib)

View More »

Las Vegas : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study in Advanced Cancer

Las Vegas : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of Necitumumab Monotherapy and the QT/QTc Interval in Patient With Advanced Solid Tumors

Las Vegas : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study to Assess the Pharmacokinetics of Ramucirumab in Combination With FOLFIRI

Las Vegas : Call for Information (Investigational Site 0387)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Las Vegas : Pfizer Investigational Site

An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)

Las Vegas : Comprehensive Caner Centers of Nevada/Summerlin Hospital

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

Las Vegas : CCOP - Nevada Cancer Research Foundation

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Las Vegas : University Medical Center of Southern Nevada

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Las Vegas : Nevada Cancer Institute

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Las Vegas : Nevada Cancer Research Foundation CCOP Updated

S0820, Adenoma and Second Primary Prevention Trial

Las Vegas : University Medical Center of Southern Nevada Updated

S0820, Adenoma and Second Primary Prevention Trial

Las Vegas :

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

Las Vegas :

Study of the Safety and Pharmacokinetics of MPDL3280A Administered Intravenously As a Single Agent to Patients With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies

North Las Vegas : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Reno : VA Sierra Nevada HealthCare System

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Reno : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Study in Head and Neck Cancer

Dover : Call for Information (Investigational Site 0204)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Lebanon : Dartmouth Hitchcock Medical Center, Norris Cotton Cancer Center Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Lebanon : GSK Investigational Site

Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents

Lebanon : 1200.131.00175 Boehringer Ingelheim Investigational Site Updated

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Lebanon : Research Site

Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer

Berlin :

Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

Berlin :

Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer

Bloomfield : New Jersey Urology, LLC Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Camden : Call for Information (Investigational Site 0448)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Cherry Hill : Investigational Site Number 840010 Updated

Early Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

View More »

Denville : Oncology and Hematology Specialists, P.A. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Denville : Call for Information (Investigational Site 0196)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Hackensack : Research Site

AMG 319 Lymphoid Malignancy FIH

Hackensack : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Hackensack : Hackensack University Medical Center Updated

Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction

Hackensack :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Lawrenceville : Premier Urology Associates, LLC / AdvanceMed Research

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Lawrenceville :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Morristown : Hematology-Oncology Associates of Northern NJ, PA; Carol G. Simon Cancer Center Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Morristown : Morristown Memorial Hospital

A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)

Mount Laurel : Delaware Valley Urology, LLC Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

New Brunswick : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of Necitumumab Monotherapy and the QT/QTc Interval in Patient With Advanced Solid Tumors

New Brunswick : Investigational Site Number 840002

A Study of the Safety and Pharmacokinetics of SAR245409 Tablets in Patients With Solid Tumors or Lymphoma

New Brunswick : Research Site

EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer

New Brunswick : Investigational Site Number 840002 Updated

Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen

New Brunswick : Cancer Institute of New Jersey Dept of Cancer Institute of NJ

Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors

New Brunswick : The Cancer Institute of New Jersey

Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration

New Brunswick :

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

New Brunswick : Cancer Institute of New Jersey

Study of Pazopanib, Paclitaxel, and Carboplatin in Patients With Advanced Solid Tumors

Newark : UMDNJ University Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Newark : Investigational Site Number 840006

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Somerville : Call for Information (Investigational Site 0327)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Sparta : Sparta Cancer Center Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Teaneck : Holy Name Medical Center

An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation

Voorhees : Cancer Institute of New Jersey at Cooper - Voorhees

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Albuquerque : Research Site

A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors

Albuquerque : New Mexico Oncology Hematology Consultants, LTD Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Albuquerque : Pfizer Investigational Site

A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer

Albuquerque : GSK Investigational Site

Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects

Albuquerque : Hematology Oncology Associates, PC

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

View More »

Albuquerque : University of New Mexico Cancer Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Santa Fe : New Mexico Cancer Care Associates Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Albany : New York Oncology Hematology, P.C. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Albany : Albany Medical Center Updated

Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer

Albany :

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Albany :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Albany :

Study of the Safety and Pharmacokinetics of MPDL3280A Administered Intravenously As a Single Agent to Patients With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies

View More »

Armonk : Call for Information (Investigational Site 0451)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Bronx : Montefiore Medical Center, Albert Einstein College of Medicine

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

Bronx : Albert Einstein Cancer Center at the Montefiore Medical Park Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Bronx : Eastchester Center for Cancer Care Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Bronx : Montefiore Medical Center Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Bronx : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Bronx :

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Bronx : Call for Information (Investigational Site 0201)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Bronx : Montefiore Medical Center

An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+

Bronx : 1200.131.00188 Boehringer Ingelheim Investigational Site Updated

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Brooklyn : Brooklyn Urology Research Group

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Brooklyn :

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Buffalo : Roswell Park Cancer Institute Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Buffalo : Zale P. Bernstein, MD, PC Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Buffalo : The Jonah Center Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Buffalo : Roswell Park Cancer Institute

A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4

Buffalo : Research Site

A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumor

Buffalo :

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Buffalo : Research Site

Open Label Extension Study of Conatumumab and AMG 479

Buffalo : Roswell Park Cancer Center

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

Buffalo : Roswell Park Cancer Institute

Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment

Buffalo :

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

Commack : Call for Information (Investigational Site 0263)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

East Setauket : North Shore Hematology/Oncology Associates Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

East Syracuse : Call for Information (Investigational Site 0033)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

East Syracuse : CCOP - Hematology-Oncology Associates of Central New York

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Elmira : Falck Cancer Center at Arnot Ogden Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Fresh Meadows : Queens Medical Associates Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Garden City :

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Garden City :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Glens Falls : Glens Falls Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Great Neck : Call for Information (Investigational Site 0258)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Great Neck : Long Island Gastrointestinal Group Updated

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

Great Neck : Research Site

Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer

Lake Success : Monter Cancer Center

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

Lake success : Call for Information (Investigational Site 0234)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Lake Success : Call for Information (Investigational Site 0230)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Lake Success : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Lake Success : North Shore/Monter Cancer Center

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

Lake Success : North Shore University Hospital-Monter Cancer Center

Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration

Manhasset : Call for Information (Investigational Site 0233)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Manhasset : North Shore University Hospital

Magnetic Resonance Imaging-Guided Laser Induced Thermal Therapy for Treatment of Metastatic Brain Tumors

Manhasset : Long Island Jewish Medical Center

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer

Mineola : Winthrop University

A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer

New York : Cornell University Division of Hematology and Medical Oncology

A Dose Escalation Study of OMP-52M51 in Subjects With Lymphoid Malignancies

New York : Memorial Sloan Kettering Cancer Center

A First-in-Human Phase 1 and Expanded Cohort Study of EPZ-5676 in Advanced Hematologic Malignancies, Including Acute Leukemia With Rearrangement of the MLL Gene

New York : Updated

A Multiple-Ascending-Dose Study of the Safety and Tolerability of REGN421(SAR153192) in Patients With Advanced Solid Malignancies

New York :

A Phase 1 Study of IPI-145 in Patients With Advanced Hematologic Malignancies

New York : Columbia University Medical Center

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

New York : University Urology Associates

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

New York : NYU Clinical Cancer Center Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

New York : NYU Langone Medical Center Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

New York : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study in Advanced Cancer

New York : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of Anti-VEGFR-3 Monoclonal Antibody IMC-3C5 in Subjects With Advanced Solid Tumors

New York : Memorial Sloan-Kettering Cancer Center

A Study of LOR-253 HCl in Patients With Advanced or Metastatic Solid Tumours

New York : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

New York : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of LY3023414 in Participants With Advanced Cancer

New York : Memorial Sloan Kettering Cancer Center

A Study of of MORAb-004 in Subjects With Solid Tumors

New York : Pfizer Investigational Site

A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer

New York :

A Study of RO5185426 (Vemurafenib) in Patients With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation

New York : Memorial Sloan Kettering Cancer Center

A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4

New York :

A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers

New York : Memorial Sloan Kettering Cancer Center

A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Castration-Resistant Prostate Cancer

New York : Research Site

A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumor

New York : Call for Information (Investigational Site 0370)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

New York : Call for Information (Investigational Site 0409)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

New York : Call for Information (Investigational Site 0408)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

New York : Memorial Sloan Kettering Cancer Center MSKCC (2)

A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma

New York : New York Downtown Hospital

An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+

New York : Mount Sinai

An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation

New York : Memorial Sloan Kettering Cancer Center

BKM120 + Carboplatin + Paclitaxel for Patients With Advanced Solid Tumors

New York : New York University Medical Center

Breath Test for Early Detection of Lung Cancer

New York : Investigational Site Number 840003 Updated

Cabazitaxel in Pediatric Patients With Refractory Solid Tumors Including Central Nervous System Tumors

New York : Memorial Sloan-Kettering Cancer Center Updated

Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors

New York : Memorial Sloan Kettering Cancer Center

Dose-Escalation Safety and Pharmacokinetic Study of Iso-Fludelone in Patients With Advanced Solid Tumors

New York : Mt Sinai Medical School, Tisch Cancer Institute Updated

Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer

New York : Department of Radiation oncology, Memorial Sloan Kettering Cancer Center

Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.

New York : Memorial Sloan-Kettering Cancer Center

HSP90 Inhibitor, AUY922, in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF), and Refractory PV/ET

New York :

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

New York : Call for Information (Investigational Site 0264)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

New York : Research Site

Panitumumab Pediatric Study

New York : Mount Sinai Medical Center

Phase Ib Study of Gemcitabine Plus Cisplatin or Carboplatin Plus Dovitinib in Patients With Advanced Solid Tumors

New York : Investigational Site Number 840009 Updated

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

New York : Columbia University

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

New York : New York University Langone Medical Center

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer

New York : NYU Cancer Center

Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration

New York : Research Site

Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer

New York : Memorial Sloan Kettering Cancer Center MSKCC (2)

Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients

New York : Memorial Sloan Kettering Cancer Center

Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of Urelumab (BMS-663513) in Subjects With Advanced and/or Metastatic Solid Tumors and Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

New York :

Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer

New York : Research Site

Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours

New York :

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

New York :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

New York : Memorial Sloan-Kettering Cancer Center

Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer

New York : Memorial Sloan-Kettering Cancer Center

Tesetaxel as First-line Therapy for Metastatic Breast Cancer

New York : Columbia University

Tracking Renal Tumors After Cryoablation Evaluation

New York : Memorial Sloan Kettering Cancer Center

Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors

New York : Melanoma and Sarcoma Service / Memorial Sloan Kettering Cancer Center

Trial of TRX518 (Anti-GITR mAb) in Stage III or IV Malignant Melanoma or Other Solid Tumors

North Hills : Integrated Medical Professionals Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Port Jefferson :

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Poughkeepsie : Hudson Valley Urology, P.C.

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Poughkeepsie : Premier Medical Group of the Hudson Valley Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Poughkeepsie : Premier Medical Group of the Hudson Valley

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Poughkeepsie :

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Rochester : University of Rochester Medical Center

A Dose Escalation Study of OMP-52M51 in Subjects With Lymphoid Malignancies

Rochester : James P. Wilmot Cancer Center Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Rochester : University of Rochester Wilmont Cancer Center

A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer

Rochester : University of Rochester Medical Center

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Rochester : Call for Information (Investigational Site 0198)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Rochester : Call for Information (Investigational Site 0241)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Rochester : James P. Wilmot Cancer Center at University of Rochester Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Rochester : University of Rochester Updated

S0820, Adenoma and Second Primary Prevention Trial

Staten Island : Staten Island Urological Research, PC Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Staten Island : Staten Island Urological Research, PC

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Staten Island :

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Stony Brook : 1200.43.00105 Boehringer Ingelheim Investigational Site Updated

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Stony Brook : 1200.131.00179 Boehringer Ingelheim Investigational Site Updated

LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Stony Brook : Research Site

Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Leukemias and Related Disorders

Syracuse : Associated Medical Professionals of New York, PLLC Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Williamsville : Windsong Comprehensive Breast Care

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

Asheville : Asheville Hematology & Oncology Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Asheville : Asheville Gastroevneterology Associates Updated

Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease

Asheville : Mission Hospitals - Memorial Campus

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Boone : Seby B. Jones Cancer Center

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer

Cary : Raleigh Hematology Oncology Associates, D.B.A., Cancer Centers of North Carolina Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

View More »

Chapel Hill : UNC/Lineberg Comprehensive Cancer Center Lineberger Comp Cancer Ctr

A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumors

Chapel Hill : University of North Carolina - Chapel Hill

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Chapel Hill : University of North Carolina, Chapel Hill

A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4

Chapel Hill : GSK Investigational Site

Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects

Chapel Hill :

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Chapel Hill : UNC - Chapel Hill

Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors

Chapel Hill :

Phase 1 Study of PI3 (Phosphatidylinositol-3)-Kinase Inhibitor BAY80-6946 With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer

Chapel Hill : University of North Carolina

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer

Chapel Hill : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Study in Head and Neck Cancer

Chapel Hill :

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

Chapel Hill : Lineberger Comprehensive Cancer Center, University of North Carolina

Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Metastatic Breast Cancer

Charlotte : Presbyterian Hospital Center for Cancer Research

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Charlotte : Presbyterian Hospital Cancer Center Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Charlotte : Blumenthal Cancer Center - Main

A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)

Charlotte : Carolinas Medical Center

A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer

Charlotte : Call for Information (Investigational Site 0014)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Charlotte : Presbyterian Cancer Center at Presbyterian Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Charlotte : Presbyterian Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Concord : Northeast Urology Research

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Durham : Research Site

A Phase 1 Dose Escalation Study of AMG 780 in Adult Subjects With Advanced Solid Tumor

Durham : Durham VA Medical Center

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Durham : Regional Cancer Care PA

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Durham : Regional Cancer Care, P.A. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Durham : Duke University Medical Center - Duke South Clinics Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Durham : Duke University Medical Center

A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)

Durham :

A Study of MPDL3280A in Combination With Avastin (Bevacizumab) or With Avastin Plus Chemotherapy in Patients With Advanced Solid Tumors

Durham : 1200.89.10005 Boehringer Ingelheim Investigational Site Updated

Afatinib (BIBW2992) in HER2-overexpressing Inflammatory Breast Cancer

Durham : Research Site

AMG 319 Lymphoid Malignancy FIH

Durham : GSK Investigational Site

Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents

Durham : Duke Cancer Institute

Dose Escalation Study of Pazopanib Plus TH-302

Durham : Duke University Medical Center

Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas

Durham : Pediatric Bone and Cord Blood, Duke Univ. Med. Center

Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation

Durham : Duke University Medical Center

Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma

Durham : Duke University Medical Center

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

Durham : Site Reference ID/Investigator# 66111

Study of ABT-700 in Subjects With Advanced Solid Tumors

Durham :

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

Fayetteville : Cape Fear Valley Health System Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Fayetteville : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Fayetteville :

Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer

Flat Rock :

Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

Gastonia : Carolina Urology Partners Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Gastonia : Call for Information (Investigational Site 0375)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Goldsboro : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Goldsboro : Southeast Medical Oncology Center

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer

Goldsboro : Wayne Memorial Hospital, Incorporated

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Goldsboro : Wayne Memorial Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Greensboro : Alliance Urology Specialists, PA

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Greensboro : The Moses Cone Regional Cancer Center

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer

Greensboro : The Moses H. Cone Regional Cancer Center

Tesetaxel as First-line Therapy for Metastatic Breast Cancer

Greenville : Leo W. Jenkins Cancer Center at ECU Medical School

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer

Hendersonville : Pardee Memorial Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Hendersonville : Park Ridge Hospital Breast Health Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Hendersonville : Margaret R Pardee Memorial Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

High Point : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Huntersville : Updated

A Pharmacokinetics Study to Investigate the Effect of Ketoconazole on Vemurafenib in Patients With BRAFV600 Mutation-Positive Metastatic Melanoma

Huntersville : Presbyterian Hospital Huntersville Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Huntersville :

A Study of MPDL3280A in Combination With Avastin (Bevacizumab) or With Avastin Plus Chemotherapy in Patients With Advanced Solid Tumors

Huntersville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of Necitumumab Monotherapy and the QT/QTc Interval in Patient With Advanced Solid Tumors

Huntersville :

Study of the Safety and Pharmacokinetics of MPDL3280A Administered Intravenously As a Single Agent to Patients With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies

Kinston : Kinston Medical Specialists Updated

Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction

Matthews : Presbyterian Hospital Matthews Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Matthews : Matthews Hematology Oncology Associates Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Mooresville : Lake Norman Hematology Oncology Specialists Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

New Bern : Coastal Carolina Health Care, PA, dba New Bern Cancer Care Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Pinehurst : First Health of the Carolinas, Moore Regional Hospital

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer

Pinehurst : FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Raleigh : Raleigh Hematology Oncology Associates, D.B.A., Cancer Centers of North Carolina Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Raleigh : Rex Cancer Center

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Raleigh :

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Raleigh :

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Raleigh : Rex Cancer Center at Rex Hospital

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer

Rocky Mount : Nash Health Care Systems

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer

Rutherfordton : Rutherford Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Salisbury : W.G. (Bill) Hefner VA Medical Center

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Statesville : Iredell Memorial Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Washington : Marion L. Shepard Cancer Center

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer

Wilmington : Call for Information (Investigational Site 0432)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Winston-Salem :

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Winston-Salem : Call for Information (Investigational Site 0315)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Winston-Salem :

Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

Winston-Salem : University of Wake Forest Baptist Medical Center

Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma

Winston-Salem : Wake Forest University Comprehensive Cancer Center

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer

Winston-Salem : Forsyth Regional Cancer Center at Forsyth Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Bismarck : St. Alexius Medical Center

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Bismarck : Call for Information (Investigational Site 0030)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Bismarck : Call for Information (Investigational Site 0224)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Bismarck : Call for Information (Investigational Site 0305)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Bismarck : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

View More »

Bismarck : Sanford Bismarck Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Bismarck :

Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer

Bismarck :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Fargo : Call for Information (Investigational Site 0153)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Fargo : Call for Information (Investigational Site 0301)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Minot : Trinity Cancer Care Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Akron : Call for Information (Investigational Site 0250)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Akron : Call for Information (Investigational Site 0323)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Akron : McDowell Cancer Center at Akron General Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Bowling Green : Wood County Oncology Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Canton : Gabrail Cancer Center

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

View More »

Canton : Call for Information (Investigational Site 0422)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Canton : Gabrail Cancer Center Research

An Exploratory Study of Gemcitabine Hydrochloride Oral Formulation (D07001-F4) in Subjects With Malignant Tumors

Canton : Investigational Site Number 840011 Updated

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

Canton : Investigational Site Number 840021

Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment

Chillicothe : Adena Regional Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Chillicothe : Adena Regional Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Cincinnati : Investigational Site Number 840001

A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors

Cincinnati : University of Cincinnati Medical Center

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Cincinnati : TriState Urologic Services PSC, Inc. dba TUG Research Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Cincinnati : Division of Urology

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Cincinnati : Investigational Site Number 840004

Dose Escalation Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies

Cincinnati : Investigational Site Number 840002

First in Man Study of SAR566658 Administered Every 3 Weeks in Patients With DS6-positive and Refractory Solid Tumors

Cincinnati :

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Cincinnati : Call for Information (Investigational Site 0231)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Cincinnati : University of Cincinnati

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer

Cincinnati : Charles M. Barrett Cancer Center at University Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Cincinnati : Investigational Site Number 840007

Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment

Cleveland : Research Site

A Phase 1 Dose Escalation Study of AMG 780 in Adult Subjects With Advanced Solid Tumor

Cleveland : Cleveland Clinic Foundation

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Cleveland : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of IMC-CS4 in Subjects With Advanced Solid Tumors

Cleveland : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Cleveland : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of Necitumumab Monotherapy and the QT/QTc Interval in Patient With Advanced Solid Tumors

Cleveland : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study to Assess the Pharmacokinetics of Ramucirumab in Combination With FOLFIRI

Cleveland : Research Site

EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer

Cleveland :

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Cleveland : Cleveland Clinic, Taussig Cancer Institute

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Cleveland : University Hospitals of Cleveland

Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors

Cleveland : Research Site

Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Leukemias and Related Disorders

Cleveland :

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

Cleveland : Cleveland Clinic

The Study of Barrett's Esophagus: What Are the Factors of Progression

Columbus : Ohio State University Comprehensive Cancer Center

A Dose Escalation Study of OMP-52M51 in Subjects With Lymphoid Malignancies

Columbus : Updated

A Multiple-Ascending-Dose Study of the Safety and Tolerability of REGN421(SAR153192) in Patients With Advanced Solid Malignancies

Columbus : Columbus Urology Research

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Columbus : Ohio State University Comprehensive Cancer Center Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Columbus : The Ohio State University Comprehensive Cancer Center

A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers

Columbus : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of IMC-CS4 in Subjects With Advanced Solid Tumors

Columbus : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Columbus : Columbus Urology Research, LLC

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Columbus :

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Columbus : Call for Information (Investigational Site 0019)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Columbus : Investigational Site Number 840008 Updated

Early Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Columbus : Ohio State University Comprehensive Cancer Center - The James

Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)

Columbus : Investigational Site Number 840015 Updated

Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen

Columbus : Ohio State University Comprehensive Cancer Center

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer

Columbus : Grant Medical Center Cancer Care

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Columbus : CCOP - Columbus

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Columbus : Doctors Hospital at Ohio Health

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Columbus : Mount Carmel Health - West Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Columbus : Riverside Methodist Hospital Cancer Care

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Columbus : Mount Carmel Health Center West Updated

S0820, Adenoma and Second Primary Prevention Trial

Columbus : Columbus CCOP Updated

S0820, Adenoma and Second Primary Prevention Trial

Columbus : Grant Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Columbus : Riverside Methodist Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Columbus : Doctors Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Columbus : The Mark H Zangmeister Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Columbus : Ohio State University

Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors

Columbus : The Ohio State University

Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer

Columbus : The Ohio State University - Comprehensive Cancer Center

Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma

Columbus :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Dayton : Samaritan North Cancer Care Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Dayton : Good Samaritan Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Dayton : CCOP - Dayton

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Dayton : Grandview Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Dayton : David L. Rike Cancer Center at Miami Valley Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Dayton : Samaritan North Health Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Dayton : Miami Valley Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Dayton : Dayton CCOP Updated

S0820, Adenoma and Second Primary Prevention Trial

Dayton : Good Samaritan Hospital - Dayton Updated

S0820, Adenoma and Second Primary Prevention Trial

Dayton : Grandview Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Delaware : Grady Memorial Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Delaware : Grady Memorial Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Dover : Gabrail Cancer Center Research

An Exploratory Study of Gemcitabine Hydrochloride Oral Formulation (D07001-F4) in Subjects With Malignant Tumors

Elyria : Hematology Oncology Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Elyria : Community Cancer Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Findlay : Blanchard Valley Medical Associates

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Findlay : Blanchard Valley Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Franklin : Middletown Regional Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Franklin : Atrium Medical Center-Middletown Regional Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Greenville : Wayne Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Greenville : Wayne Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Kettering : Charles F. Kettering Memorial Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Kettering : Kettering Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Lancaster : Fairfield Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Lancaster : Fairfield Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Lima : Lima Memorial Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Marietta : Strecker Cancer Center at Marietta Memorial Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Marietta : Marietta Memorial Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Maumee : Northwest Ohio Oncology Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Middleburg Heights : SouthWest Urology Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Middletown : Investigational Site Number 840019 Updated

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

Middletown : Research Site

Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer

Mount Vernon : Knox Community Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Mount Vernon : Knox Community Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Newark : Licking Memorial Cancer Care Program at Licking Memorial Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Newark : Licking Memorial Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Oregon : St. Charles Mercy Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Oregon : Toledo Clinic - Oregon

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Portsmouth : Southern Ohio Medical Center Cancer Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Portsmouth : Southern Ohio Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Springfield : Community Hospital of Springfield and Clark County

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Springfield : Springfield Regional Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Sylvania : Flower Hospital Cancer Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Tiffin : Mercy Hospital of Tiffin

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Toledo : Call for Information (Investigational Site 0399)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Toledo : Toledo Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Toledo : CCOP - Toledo Community Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Toledo : Toledo Clinic, Incorporated - Main Clinic

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Toledo : St. Vincent Mercy Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Toledo : Medical University of Ohio Cancer Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Toledo : St. Anne Mercy Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Troy : UVMC Cancer Care Center at Upper Valley Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Troy : Upper Valley Medical Center Updated

S0820, Adenoma and Second Primary Prevention Trial

Wauseon : Fulton County Health Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Westerville : Mount Carmel St. Ann's Cancer Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Westerville : Saint Ann's Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Wright-Patterson Afb : United States Air Force Medical Center - Wright-Patterson

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Xenia : Ruth G. McMillan Cancer Center at Greene Memorial Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Xenia : Greene Memorial Hospital Updated

S0820, Adenoma and Second Primary Prevention Trial

Zanesville : Genesis - Good Samaritan Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Zanesville : Genesis HealthCare System Updated

S0820, Adenoma and Second Primary Prevention Trial

Altus : Cancer Centers of Southwest Oklahoma Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Duncan : Cancer Centers of Southwest Oklahoma Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Lawton : Cancer Centers of Southwest Oklahoma Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Oklahoma City : University of Oklahoma Health Sciences Center

A Multicenter "Ablate and Resect" Study of Novilase® Interstitial Laser Therapy for the Ablation of Small Breast Cancers

Oklahoma City : Updated

A Multiple-Ascending-Dose Study of the Safety and Tolerability of REGN421(SAR153192) in Patients With Advanced Solid Malignancies

View More »

Oklahoma City : University of Oklahoma Health Sciences Center

A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)

Oklahoma City : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study in Advanced Cancer

Oklahoma City : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of LY3023414 in Participants With Advanced Cancer

Oklahoma city :

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Oklahoma City : Call for Information (Investigational Site 0325)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Oklahoma City : Pfizer Investigational Site

An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)

Oklahoma City : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Oklahoma City :

Dose Escalation Study of MLN0128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies

Oklahoma City : University of Oklahoma

Dose Escalation Study of the Safety and Pharmacokinetics of ME-344 Single Agent for Refractory Solid Tumors

Oklahoma City : University of Oklahoma Stephenson Cancer Center

First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IMGN853 in Adults With Ovarian Cancer and Other FOLR1-Positive Solid Tumors

Oklahoma City : University of Oklahoma

Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer

Oklahoma City : Peggy and Charles Stephens Oklahoma Cancer Center

Safety Study of X-82 in Patients With Advanced Solid Tumors

Oklahoma City : Oklahoma University

Study of PI3 Kinase/mTOR Inhibitor BEZ235 Twice Daily for Advanced Solid Tumors

Oklahoma City : Univ. Oklahoma Health Science Center

Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors

Tulsa : Urologic Specialists of Oklahoma Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Tulsa : Tulsa Cancer Institute

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

Beaverton : Call for Information (Investigational Site 0401)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Bend : GSK Investigational Site Updated

Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer

Clackamas : Clackamas Radiation Oncology Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Coos Bay : Bay Area Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Eugene :

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

View More »

Grants Pass : Three Rivers Community Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Gresham : Legacy Mount Hood Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Medford : Providence Cancer Center at PMCC

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Medford : Dubs Cancer Center at Rogue Valley Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Milwaukie : Providence Milwaukie Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Newberg : Providence Newberg Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Oregon City : Willamette Falls Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Portland : Providence Cancer Center Oncology and Hematology Care Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Portland : Northwest Cancer Specialists, P.C. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Portland : GSK Investigational Site Updated

ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D

Portland : Pfizer Investigational Site

An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)

Portland : Oregon Health & Science University

Assessing Dynamic Magnetic Resonance (MR) Imaging in Patients With Recurrent High Grade Glioma Receiving Chemotherapy

Portland : Portland Providence Medical Center

Combination Study of Urelumab and Rituximab in Patients With B-cell Non-Hodgkins Lymphoma or CLL

Portland : Research Site

Panitumumab Pediatric Study

Portland : Providence Cancer Center at Providence Portland Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Portland : Legacy Good Samaritan Hospital & Comprehensive Cancer Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Portland : CCOP - Columbia River Oncology Program

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Portland : Providence St. Vincent Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Portland : Oregon Health & Science University

Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration

Portland : Providence Cancer Center

Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma Multiforme or Other Recurrent Malignant Gliomas

Portland : Oregon Health and Sciences University

Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma Multiforme or Other Recurrent Malignant Gliomas

Portland : Providence Portland Med Ctr

Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of Urelumab (BMS-663513) in Subjects With Advanced and/or Metastatic Solid Tumors and Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

Portland :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Portland : Oregon Health and Science University

Treosulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders

Springfield : Willamette Valley Cancer Center

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Springfield : Oregon Urology Institute Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Tualatin : Northwest Cancer Specialists, P.C. Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Tualatin : Legacy Meridian Park Medical Center Updated

Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer

Tualatin : Legacy Meridian Park Hospital

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Abington : Pfizer Investigational Site

A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer

Allentown : Breast Care Specialist, PC

Clinical Evaluation of Tissue Sampling Bias in Histologic Evaluation of Sentinel Lymph Nodes in Breast Cancer

Allentown : Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Bala Cynwyd : Urologic Consultants of Southeaster PA LLP

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Bala Cynwyd : Urologic Consultants of SE PA Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

View More »

Bala Cynwyd : Urology Consultants of Southeastern Pennsylvania

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Bethlehem : Call for Information (Investigational Site 0417)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Bryn Mawr : Urology Health Specialists, LLC Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Bryn Mawr :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Carnegie : GSK Investigational Site

Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study

Easton : St. Luke's Hospital and Health Network

A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer

Erie : The Regional Cancer Center Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Gettysburg : Gettysburg Cancer Center Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Hershey : Pennsylvania State University College of Medicine Updated

Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors

Lancaster : Urological Associates Of Lancaster

A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer

Lancaster : Urological Associates of Lancaster Updated

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Lancaster : Urological Associates of Lancaster

A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Lancaster :

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Lancaster :

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Langhorne : St. Mary Medical Center

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

Philadelphia : University of Pennsylvania

A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer

Philadelphia :

A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction

Philadelphia : University of Pennsylvania, Site #013

A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113

Philadelphia : Fox Chase Cancer Center

A Safety Study of Oral ZSTK474 in Patients With Cancer

Philadelphia : Thomas Jefferson University Hospital

A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer

Philadelphia : Research Site

A Study of AMG 820 in Subjects With Advanced Solid Tumors

Philadelphia : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2875358 in Patients With Advanced Cancer

Philadelphia : University of Pennsylvania Abramson Cancer Center

A Study of MGCD265 Given With Erlotinib or Docetaxel in Subjects With Advanced Malignancies or Non-Small Cell Lung Cancer

Philadelphia : Fox Chase Cancer Center

A Study of of MORAb-004 in Subjects With Solid Tumors

Philadelphia :

A Study of RO5185426 (Vemurafenib) in Patients With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation

Philadelphia :

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Philadelphia : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study to Assess the Pharmacokinetics of Ramucirumab in Combination With FOLFIRI

Philadelphia :

A Study to Assess the Potential Effects of Rifampin on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies

Philadelphia : Research Site

A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumor

Philadelphia : Call for Information (Investigational Site 0026)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Philadelphia : Call for Information (Investigational Site 0447)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Philadelphia : Call for Information (Investigational Site 0021)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)

Philadelphia : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Philadelphia : Hospital of the University of Pennsylvania Updated

Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer

Philadelphia :

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Philadelphia : University of Pennsylvania Updated

Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction

Philadelphia :

Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

Philadelphia : 1200.43.00103 Boehringer Ingelheim Investigational Site Updated

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Philadelphia : 1200.43.